Grupos de Investigación

Publicaciones en 2025

Gros B, Martínez PEA, Cuerva MO, Aparicio-Serrano A, Jiménez EG, Lucio AS, Pleguezuelo M, Molina AJH, Ruiz FJS. Diagnostic yield of biliary brush cytology via endoscopic retrograde cholangiopancreatography: a 7-year tertiary center experience. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 2025. 447-454. DOI:10.17235/reed.2025.11158/2025. IF: 4          Q1     D3

Fuentes A, Estévez-Escobar M, De Salazar A, Escolano ER, Montiel N, Macías M, Alados JC, Aguilar JC, Pérez AB, Baena PB, Cabezas T, Camelo-Castillo A, Palop B, Grande RG, Viciana I, Bandera JMP, Sánchez FF, Lozano MD, Giráldez A, Domínguez MD, Maté CJ, Arellano ER, Cordero P, De Luna FFA, del Pino P, Salgado AD, Pérez D, Sampedro A, Garrido MAL, Luzón-García MP, Salas-Coronas J, Roldán C, García F, Freyre C, Rodríguez GS, Rosales-Zabal JM, Domínguez-Hernández R, Casado M, García F. Double reflex testing improves the efficacy and cost effectiveness of hepatitis delta diagnosis in southern Spain. SCIENTIFIC REPORTS. 2025. -. DOI:10.1038/s41598-025-00101-7. IF: 3,9          Q1     D2

Espejo-Cruz ML, González-Rubio S, Espejo JJ, Zamora-Olaya JM, Prieto-Torre M, Linares CI, Ruiz-Ramas A, Jiménez-Arranz A, Guerrero-Misas M, Barrera-Baena P, Poyato-González A, Montero JL, Sánchez-Frías M, Ayllón MD, Rodríguez-Perálvarez ML, de la Mata M, Ferrín G. Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma. JOURNAL OF TRANSLATIONAL MEDICINE. 2025. -. DOI:10.1186/s12967-025-06092-3. IF: 7,5          Q1     D2

Gómez-Orellana AM, Rodríguez-Perálvarez ML, Guijo-Rubio D, Gutiérrez PA, Majumdar A, McCaughan GW, Taylor R, Tsochatzis EA, Hervás-Martínez C. Gender-Equity Model for Liver Allocation Using Artificial Intelligence (GEMA-AI) for Waiting List Liver Transplant Prioritization. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2025. 2187-2196. DOI:10.1016/j.cgh.2024.12.010. IF: 12,2          Q1     D1

Diaz-González A, Schregel I, Carballo L, Alvarez-Navascués C, Frisancho-Morales E, Miquel M, Retortillo MG, Gómez J, Horta D, Mateos B, Engel B, Volmer F, del Barrio M, Rodriguez-Tajes S, Olivas I, Hartl J, González CA, Hernández-Guerra M, Castello I, Pérez-Medrano I, González-Santiago JM, Arencibia A, Gómez A, Rodriguez-Perálvarez M, Crespo J, Sala M, Salcedo M, Barreira-Diaz A, Riveiro-Barciela M, Taubert R, Schramm C, Londoño MC, Registry C. Isolated IgG elevation in patients with persistently normal transaminases does not affect the outcome of autoimmune hepatitis. JHEP REPORTS. 2025. -. DOI:10.1016/j.jhepr.2025.101562. IF: 7,5          Q1     D2

Del Barrio M, Ferreiro E, Gómez E, Caballero A, Salcedo M, Santos-Laso A, González-Pascual A, Sousa JM, Gómez J, Pérez-Medrano I, Calvo MQ, Fernández-Rodriguez C, Mateos B, Arencibía A, Riveiro-Barciela M, Vaz-Romero I, Horta D, Conde I, El Hajra I, Rodríguez-Perálvarez M, Cuerva MO, Sala M, García-Retortillo M, Hernáez T, Miquel M, González-Santiago JM, Crespo J, Londoño MC, Díaz-González A. Occurrence and Management of Opportunistic Infections in Patients With Autoimmune Hepatitis: A Spanish Multicentre Study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2025. 493-503. DOI:10.1111/apt.70208. IF: 6,7          Q1     D1

Sanz-Sanz J, Gutiérrez-Casbas A, Plaza Z, Gratacós J, Rodríguez-Lago I, Marín-Jiménez I, Trujillo-Martín E, Perez-Pampín E, Barreiro-de Acosta M, Hernández-Hernández MV, Carrillo-Palau M, García-Vivar ML, Muñoz-Villafranca MC, Ladehesa-Pineda ML, Iglesias-Flores E, Merino-Argumánez C, González-Lama Y, Arévalo-Salaet M, Calvet X, Díaz-Gonzalez F. Prevalence of Undiagnosed Inflammatory Bowel Disease in Spondyloarthritis Patients. JOURNAL OF CLINICAL MEDICINE. 2025. -. DOI:10.3390/jcm14134569. IF: 2,9          Q1     D2

Navarro L, Perez-Bartivas L, Ponferrada D, Cejas J, Camús JA, Rangel N, Porras M, Estevez CM, Eito AP, Rioja P, Alvarez M, Aranda E, de la Haba-Rodríguez. Prioritizing breast cancer surgeries: insights from the KRONOS SCORE. FRONTIERS IN ONCOLOGY. 2025. -. DOI:10.3389/fonc.2024.1465154. IF: 3,3          Q2     D4

Hermán-Sánchez N, del Rio-Moreno M, Ciria R, Sánchez-Frias ME, Fernández-Barrena MG, Uriarte I, Chicano-Galvez E, Ortea I, Peralbo-Molina A, Briceño J, Avila MA, Rodríguez-Perálvarez M, Luque RM, López-Cánovas JL, Gahete MD. Quantitative proteomic analysis unveils a critical role of VARS1 in hepatocellular carcinoma aggressiveness through the modulation of MAGI1 expression. MOLECULAR CANCER. 2025. -. DOI:10.1186/s12943-024-02206-5. IF: 33,9          Q1     D1

Caballero-Gómez J, Casares-Jimenez M, Gallo-Marín M, Pereira-Pardo S, Beato-Benítez A, Poyato A, Guerra R, Avellón A, Schilling-Loeffler K, Freyre-Carrillo C, García-Bocanegra I, Jiménez-Martin D, Corona-Mata D, Viciana I, Fajardo T, Muñoz-Chimeno M, Quevedo MA, Rios-Muñoz L, Pérez AB, Cano-Terriza D, Macías J, Fuentes A, Johne R, Rivero-Juarez A, Rivero A. Rat hepatitis E virus as an aetiological agent of acute hepatitis of unknown origin. JOURNAL OF HEPATOLOGY. 2025. 662-669. DOI:10.1016/j.jhep.2025.02.027; 10.1016/j.jhep.2025.02.027. IF: 33          Q1     D1

Roseira J, Estevinho MM, Gros B, Marafini I, Solitano V, Sousa P, Carretero C, Zou W, Parsa N, Charabaty A, Kunovsky L. Advances in endoscopy in IBD diagnostics and management. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY. 2025. -. DOI:10.1016/j.bpg.2025.102055. IF: 4          Q1     D3

Baldán-Martín M, Iloro I, Azkargorta M, Soleto I, Orejudo M, Ramirez C, Mercado J, Suárez-Trujillo F, Sánchez-Sánchez C, Garre A, Riestra S, Rivero M, Gutiérrez A, Rodríguez-Lago I, Fernández-Salazar L, Ceballos D, Benítez JM, Aguas M, Baston-Rey I, Bermejo F, Casanova MJ, Lorente-Poyatos RH, Ber Y, Ginard D, Esteve M, De Francisco R, García MJ, Francés R, Cabriada JL, Soto P, Nos P, Acosta MBD, Guerra I, Cruz DH, Cajal MD, Royo V, Aceituno M, Martín-Cofreces NB, Elortza F, Gisbert JP, Chaparro M. Comprehensive proteomic profile in newly diagnosed patients with inflammatory bowel disease: identification of potential biomarkers. JOURNAL OF CROHNS & COLITIS. 2025. -. DOI:10.1093/ecco-jcc/jjaf177. IF: 8,7          Q1     D1

Aguilera V, Moreno SR, Conde I, Rubín A, Carvalho-Gomes A, Romero M, Zamora-Olaya J, Gómez-Bravo MA, Fuentes-Valenzuela E, Dopazo C, Bilbao N, Gonzalez A, Sanchez-Martinez A, Pascual S, Rivera-Esteban J, Herrero JI, Lorente S, Cuadrado-Lavin A, Nogueras F, Martínez-Arenas L, González-Grande R, Berenguer M, Rodriguez-Perálvarez M. Cytomegalovirus Reactivation Is Associated With Lower Rates of Hepatocellular Carcinoma Recurrence After Liver Transplantation. TRANSPLANT INTERNATIONAL. 2025. -. DOI:10.3389/ti.2025.14553. IF: 3          Q1     D2

Gros B, Peraza J, Bassi M, Sleiman J, Abdelhalim S, Park E, Wong SY, Agrawal M, Grinspan LT, Charabaty A. Disparities in Gender and Race Representation Among Authors of Inflammatory Bowel Disease Clinical Trials. JOURNAL OF CROHNS & COLITIS. 2025. -. DOI:10.1093/ecco-jcc/jjae184. IF: 8,7          Q1     D1

Chhibba T, Gros B, King JA, Windsor JW, Gorospe J, Leibovitzh H, Xue M, Turpin W, Croitoru K, Ananthakrishnan AN, Gearry RB, Kaplan GG. Environmental risk factors of inflammatory bowel disease: toward a strategy of preventative health. JOURNAL OF CROHNS & COLITIS. 2025. -. DOI:10.1093/ecco-jcc/jjaf042. IF: 8,7          Q1     D1

Sala M, Pascual S, Roca MRR, Rodriguez M, Chiminazzo V, Sala M, Pascual S, Roca MRR, Matilla AM, Campos M, Delgado M, Ferrerez MT, Montero JL, Guerrero A, Aracil C, Rodriguez-Lopez C, Sogbe M, Olmo JF, Minguez B, Vallejo-Senra N, Unceta PR, Clos A, Diaz-Bethencourt D, Sanchez AG, Castro RQ, Bustamante J, Perello C, Ponce JJU, Serra HA, Llamoza-Torres CJ, Montoliu S, Fernandez-Marcos C, Guiberteau A, Vergara M, Fernandez-Lopez AM, Gutierrez-Garcia ML, Hernaez-Alsina T, Coll S, Cuyas B, Morillas MJ, Olmedo SR, Fernandez-Bermejo M, Roget M, Ramos IC, Rio GPD, Rifa R, Gacho PC, Barrio ML, Gomez-Rubio M, Penas I, Cachero A, Reig M, Gonzalez-Santiago JM, Giraldez A, Guerrero M, Segarra JX, Romero-Gutierrez M, Lledo JL, Diaz-Gonzalez A, Cortes-Garcia L, Delgado C, Vazquez-Rodriguez S, Serra I, Inarrairaegui M, Fernandez-Marcos C, Rodriguez-Gonzalez M, Barrio ML, Diaz-Bethencourt D, Lazaro M, Bermudez-Ramos M, Lue ALR, Molina E, Macias-Rodriguez MA, Varela M. Evolving epidemiology of HCC in Spain. JHEP REPORTS. 2025. -. DOI:10.1016/j.jhepr.2025.101336. IF: 7,5          Q1     D2

Orejudo M, Gómez MJ, Riestra S, Rivero M, Gutiérrez A, Rodríguez-Lago I, Fernández-Salazar L, Ceballos D, Benítez JM, Aguas M, Bastón-Rey I, Bermejo F, Casanova MJ, Lorente-Poyatos RH, Ber Y, Ginard D, Esteve M, de Francisco R, García MJ, Francés R, Rodríguez A, Suárez NA, del Río EG, Soto P, Nos P, Acosta MBD, Guerra I, Cruz DH, Cajal MD, Royo V, Aceituno M, Aldars-García L, Garre A, Ramírez C, Soleto I, Schuppe-Koistinen I, Engstrand L, Baldán-Martín M, Sánchez-Cabo F, Gisbert JP, Chaparro M. Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. 2025. -. DOI:10.3389/fcimb.2025.1595884. IF: 4,8          Q1     D2

Angelico R, Riani EB, De Martin E, Parente A, Foguenne M, Sensi B, Rodríguez-Perálvarez ML. Immunosuppression protocols for emerging oncological indications in liver transplantation: A systematic review and pooled analysis. LIVER TRANSPLANTATION. 2025. 181-189. DOI:10.1097/LVT.0000000000000499. IF: 3,9          Q1     D1

González-Muñoza C, Giordano A, Ricart E, Nos P, Iglesias E, Gisbert JP, García-López S, Mesonero F, Pascual I, Tardillo C, Rivero M, Riestra S, Mañosa M, Zabana Y, Gomollón F, Calvet X, García-Sepulcre MF, Gutiérrez A, Pérez-Calle JL, Sierra-Ausín M, Bermejo F, Arias L, Barreiro-de Acosta M, Barrio J, Lorente R, Guardiola J, Varela P, Ponferrada-Díaz A, Marín-Jiménez I, Pascual CM, Garcia-Planella E, Domènech E. Influence of Familial Inflammatory Bowel Disease History on the Use of Immunosuppressants, Biological Agents and Surgery in Patients with Pediatric-Onset of the Disease in the Era of Biological Therapies. Results from the ENEIDA Registry. JOURNAL OF CLINICAL MEDICINE. 2025. -. DOI:10.3390/jcm14103352. IF: 2,9          Q1     D2

Madero-Velázquez L, Minguez A, Medina L, Ramirez J, Moreno N, Amorós C, Garcia-Brenes MA, Mena R, Benitez J, Gimeno-Pitarch L, Maroto N, Suria C, Rodriguez-Moranta F, Ordas I, Ruiz L, Garcia-Brenes MA, Gutiérrez A, de Celix CR, Cárdenas K, Ginard D, Medina L, Pédrero N, Plaza R, Salmoral R, Martinez-Pérez T, Algara V, Merino E, Zabana Y, Gutiérrez A. Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2025. 674-684. DOI:10.1002/ueg2.12740. IF: 8,7          Q1     D1

Casanova MJ, de Célix CR, Riestra S, Lucendo AJ, Benitez JM, Navarro-Llavat M, Barrio J, Morales-Alvarado VJ, Rivero M, Busquets D, Leo-Carnerero E, Nantes-Castillejo O, Navarro P, Van Domselaar M, Gutierrez-Casbas A, Alonso-Abreu I, Acosta MBD, Fernandez-Salazar L, Iborra M, Martín-Arranz MD, Garcia-Morales N, Guardiola J, Bouhmidi-Assakali A, Esteve M, Munoz-Villafranca C, Rodriguez-Lago I, Ceballos D, Guerra I, Mañosa M, Marin-Jiménez I, Vera-Mendoza I, Garre A, Chaparro M, Gisbert JP. Long-Term Outcomes Following Withdrawal of Anti-Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long-Term Study of GETECCU. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2025. 59-71. DOI:10.1111/apt.70172. IF: 6,7          Q1     D1

Bancil AS, Gros B, Banerjee R, Charabaty A, Tozer P, Blackwell J. Milestone papers that changed clinical practice in IBD. FRONTLINE GASTROENTEROLOGY. 2025. 330-338. DOI:10.1136/flgastro-2025-103068. IF: 3,1          Q2     D4

Rodríguez-Lago I, Marigorta UM, Mateos B, Mañosa M, Márquez-Mosquera L, Menchén L, Rodríguez-Moranta F, Alonso I, Aguas M, Alonso-Galán H, Borràs P, Castro B, Domenech E, Ferreiro-Iglesias R, de Francisco R, García-Alonso FJ, García N, García-Bosch O, Gargallo C, Gisbert JP, Iglesias E, Mesonero F, de Zárate JO, Ramos L, Sáinz E, Ladrón P, Suria C, Ferrer CS, Tejido C, Varela P, Vicente R, Zabana Y, Castany G, Rodríguez E, Gutierrez A, Acosta MBD. Natural history, immunological and genetic characteristics of preclinical inflammatory bowel disease (EARLY): study protocol for a prospective cohort study. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2025. -. DOI:10.1177/17562848251338647. IF: 3,4          Q2     D4

Mauro E, Rodríguez- Perálvarez M, D'Alessio A, Crespo G, Piñero F, De Martin E, Colmenero J, Pinato DJ, Forner A. New Scenarios in Liver Transplantation for Hepatocellular Carcinoma. LIVER INTERNATIONAL. 2025. -. DOI:10.1111/liv.16142. IF: 5,2          Q1     D2

Mateos AMC, de la Fuente GAC, Gros B. Paradigm Shift in Inflammatory Bowel Disease Management: Precision Medicine, Artificial Intelligence, and Emerging Therapies. JOURNAL OF CLINICAL MEDICINE. 2025. -. DOI:10.3390/jcm14051536. IF: 2,9          Q1     D2

Peris MA, Francisco JD, Mateu PN, Piudo AE, Moya MC, Gros B, Martín-Arranz MD, Boquet EM, Agustín SI, Martínez AV, Correcher M, Barreiro-de Acosta M, Ciria MM, Rodriguez-Moranta F, Zabana Y, Casbas AG. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on the use of Telemedicine in Inflammatory Bowel Disease. GASTROENTEROLOGIA Y HEPATOLOGIA. 2025. -. DOI:10.1016/j.gastrohep.2024.502320. IF: 1,9          Q3     D

Sánchez-Torrijos Y, Fernández-Alvarez P, Rosales JM, Pérez-Estrada C, Alañón-Martinez P, Rodriguez-Perálvarez M, Jimeno C, Del Pino P, Garcia-Garcia A, López-Garrido A, Garcia-Cortés M, Romero G, Romero-Gómez M, Casado M, Carmona I, Ampuero J. Prognostic implications of recompensation of decompensated cirrhosis after SVR in patients with hepatitis C. JOURNAL OF HEPATOLOGY. 2025. 652-661. DOI:10.1016/j.jhep.2025.02.041; 10.1016/j.jhep.2025.02.041. IF: 33          Q1     D1

Caballero-Mateos AM, Brunet-Mas E, Gros B. Systemic Consequences of Inflammatory Bowel Disease Beyond Immune-Mediated Manifestations. JOURNAL OF CLINICAL MEDICINE. 2025. -. DOI:10.3390/jcm14227984. IF: 2,9          Q1     D2

Mesonero F, Alicia LG, José MB, Cristina RD, Ignacio MJ, Cristina SF, Albert MC, Esteban FV, Alejando M, Andrés C, Cristina R, Agnès FC, Jerusalén GPC, Begoña AH, José GM, Xavier SOJ, Carmen RGM, Francisco LRS, Ignacio O, Daniel MR, María GV, Angel PD, Iria BR, María BJ, Cristina R, Alejandro LGE, Genaro DGP, Leyanira T, Alejandro HC, Lorena B, Gisela P, Eduard B, Martín I, Miquel MC, Yamile Z, Ana G. Therapeutic management and risk of colectomy in patients with acute severe ulcerative colitis and previous exposure to anti-tumor necrosis factor drugs: a comparative study of GETECCU. JOURNAL OF CROHNS & COLITIS. 2025. -. DOI:10.1093/ecco-jcc/jjaf183. IF: 8,7          Q1     D1

Gros B, Constantine-Cooke N, Kennedy J, Elford AT, O'Hare C, Noble C, Jones GR, Arnott ID, Lees CW, Plevris N. Tofacitinib Versus Vedolizumab Among Bio-naive Patients With Ulcerative Colitis: A Real-World Propensity-Weighted Comparison. JOURNAL OF CROHNS & COLITIS. 2025. -. DOI:10.1093/ecco-jcc/jjae188. IF: 8,7          Q1     D1

Elford AT, Constantine-Cooke N, Jenkinson PW, Gros B, Plevris N, Lyons M, Ong S, Greenlees N, Velasco-Pardo V, O'Hare C, Ventham NT, Henderson P, Wilson DC, Din S, Noble CL, Jones GR, Arnott I, Lees CW. Twenty-Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, Scotland. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2025. 699-709. DOI:10.1111/apt.70240. IF: 6,7          Q1     D1

Mesonero F, Zabana Y, Fernández-Clotet A, Solá A, Caballol B, Leo-Carnerero E, García MJ, Bertoletti F, Bastida G, Suris G, Casis B, Ferreiro-Iglesias R, Calafat M, Jiménez I, Miranda-Bautista J, Lamuela LJ, Fajardo I, Torrealba L, Nájera R, Sáiz-Chumillas RM, González-Partida I, Vicuña M, García-Morales N, Gutiérrez A, López-García A, Benitez JM, de Célix CR, Tejido C, Brunet E, Hernandez-Camba A, Suárez C, Rodríguez-Lago I, Piqueras M, Castaño A, Ramos L, Sobrino A, Rodríguez-Grau MC, Elosua A, Montoro M, Baltar R, Huguet JM, Hermida B, Caballero-Mateos A, Sánchez-Guillén L, Bouhmidi A, Pajares R, Baston-Rey I, López-Sanromán A, Albillos A, Barreiro-de Acosta M. Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU. DIGESTIVE AND LIVER DISEASE. 2025. 566-573. DOI:10.1016/j.dld.2024.09.023. IF: 3,8          Q2     D4

 

 

 

 

Publicaciones en 2024

Zamora-Olaya JM, Tejero-Jurado R, Alañón-Martínez PE, Prieto-Torre M, Rodríguez-Medina C, Montero JL, Sánchez-Frías M, Briceño J, Ciria R, Barrera P, Poyato A, de la Mata M, Rodríguez-Perálvarez ML. Donor Atheromatous Disease is a Risk Factor for Hepatic Artery Thrombosis After Liver Transplantation. CLINICAL TRANSPLANTATION. 2024. DOI: 10.1111/ctr.15405. IF: 1,9      Q2  D5

Rodríguez-Perálvarez ML, de la Rosa G, Gómez-Orellana AM, Aguilera MV, Vicente TP, Pereira S, Ortiz ML, Pagano G, Suarez F, Grande RG, Cachero A, Tomé S, Barreales M, Mateos RM, Pascual S, Romero M, Bilbao I, Martín CA, Otón E, Diéguez LG, Espinosa MD, Milla AA, Fernández GB, Lorente S, Lavín AC, García AR, Cano CS, Cepeda-Franco C, Pons JA, Colmenero J, Guijo-Rubio D, Otero A, Navarrete AA, Moreno SR, Soler MR, Martínez CH, Gastaca M. GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study. ECLINICALMEDICINE. 2024. DOI: 10.1016/j.eclinm.2024.102737. IF: 9,6      Q1  D1

Lagal DJ, Ortiz-Alcántara A, Pedrajas JR, Mcdonagh B, Bárcena JA, Requejo-Aguilar R, Padilla CA. Loss of peroxiredoxin 6 alters lipid composition and distribution resulting in increased sensitivity to ferroptosis. BIOCHEMICAL JOURNAL. 2024. 1997-2015. DOI: 10.1042/BCJ20240445. IF: 4,4      Q2  D3

Ferreiro-Iglesias R, Silva SP, Marín S, Casanova MJ, Mañosa M, González-Muñoza C, de Francisco R, Caballol B, Arias L, Piqueras M, Zabana Y, Rivero M, Calvet X, Mesonero F, Trastoy PV, Nistal RB, Perosanz RG, Vega P, Gonzalez-Vivo M, Iborra M, Bermejo F, Madero L, Rodríguez-Lago I, Gonzalez MR, Vera I, Díaz AP, Vela M, Medina LT, Van Domselaar M, Gomollón F, Iglesias E, Gisbert JP, Calafat M, Giordano A, Pérez-Martínez I, Ricart E, Sicilia B, Mena R, Esteve M, Rivas C, Brunet-Mas E, Fernández C, Turrión MAD, Jiménez BV, Calvo MQ, Expósito CR, Márquez-Mosquera L, Nos P, Granja A, Gutiérrez A, Cabriada JL, Cruz DH, Calvo M, Pérez JP, Díaz YR, Casal DB, Menacho M, Leal C, Lucendo AJ, Royo V, Olivares S, Herrero BA, Carrillo-Palau M, Alvarez PG, Marcos NM, Martínez-Pérez TD, Villafranca MCM, Almela P, Argüelles-Arias F, Legido J, Coronel AMF, Nieto L, Domènech E, Acosta MBD. Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024. 604-612. DOI: 10.1111/apt.18133. IF: 6,6      Q1  D1

Alvarado-Tapias E, Maya-Miles D, Albillos A, Aller R, Ampuero J, Andrade RJ, Arechederra M, Aspichueta P, Banales JM, Blas-Garcia A, Caparros E, Delgado TC, Carrillo-Vico A, Claria J, Cubero FJ, Diaz-Ruiz A, Fernandez-Barrena MG, Fernandez-Iglesias A, Fernandez-Veledo S, Frances R, Gallego-Duran R, Gracia-Sancho J, Irimia M, Lens S, Martinez-Chantar ML, Minguez B, Munoz-Hernandez R, Nogueiras R, Ramos-Molina B, Riveiro-Barciela M, Rodriguez-Peralvarez ML, Romero-Gomez M, Sabio G, Sancho-Bru P, Ventura-Cots M, Vidal S, Gahete MD. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH). GASTROENTEROLOGIA Y HEPATOLOGIA. 2024. DOI: 10.1016/j.gastrohep.2024.502207. IF: 2,2      Q3  D

Aldars-García L, Gil-Redondo R, Embade N, Riestra S, Rivero M, Gutiérrez A, Rodríguez-Lago I, Fernández-Salazar L, Ceballos D, Benitez JM, Aguas M, Baston-Rey I, Bermejo F, Casanova MJ, Lorente R, Ber Y, Ginard D, Esteve M, de Francisco R, García MJ, Francés R, Pescador AR, Velayos B, del Río EG, Pedrosa SM, Sabater AM, Acosta MBD, Algaba A, Gil CV, Rivas O, Royo V, Aceituno M, Garre A, Baldán-Martín M, Ramírez C, Sanz-García A, Lozano JJ, Sidorova J, Millet O, Bernardo D, Gisbert JP, Chaparro M. Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naive Inflammatory Bowel Disease Patients. INFLAMMATORY BOWEL DISEASES. 2024. 167-182. DOI: 10.1093/ibd/izad154. IF: 4,5      Q1  D3

Calafat M, Torres P, Tosca-Cuquerella J, Sánchez-Aldehuelo R, Rivero M, Iborra M, González-Vivo M, Vera I, de Castro L, Bujanda L, Barreiro-de Acosta M, González-Muñoza C, Calvet X, Benítez JM, Llorente-Barrio M, Surís G, Cañete F, Arias-García L, Monfort D, Castaño-García A, Garcia-Alonso FJ, Huguet JM, Marín-Jímenez I, Lorente R, Martín-Cardona A, Ferrer JA, Camo P, Gisbert JP, Pajares R, Gomollón F, Castro-Poceiro J, Morales-Alvarado J, Llaó J, Rodríguez A, Rodríguez C, Pérez-Galindo P, Navarro M, Jiménez-García N, Carrillo-Palau M, Blázquez-Gómez I, Sesé E, Almela P, de la Piscina PR, Taxonera C, Rodríguez-Lago I, Cabrinety L, Vela M, Mínguez M, Mesonero F, García MJ, Aguas M, Márquez L, Porto MS, Pineda JR, García-Etxebarría K, Bertoletti F, Brunet E, Mañosa M, Domènech E. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2024. DOI: 10.1177/17562848231221713. IF: 3,9      Q1  D2

Rodríguez-Lago I, Cañete F, Guerra-del-Río E, Herrera-deGuise C, Iglesias E, Leo E, Zabana Y, Acosta MBD, Ginard D, Cabriada JL. Combination of granulocyte-monocyte apheresis and tofacitinib: Multicentre and retrospective study. GASTROENTEROLOGIA Y HEPATOLOGIA. 2024. 727-733. DOI: 10.1016/j.gastrohep.2024.01.004. IF: 2,2      Q3  D

Rodríguez-Lago I, Herrera-deGuise C, Boscá-Watts M, Rodríguez C, Leo-Carnerero E, Iñiguez MC, Cañete F, Chacón S, Cuarán C, Elorza A, Guerra-del-Río E, Iglesias E, Sánchez D, Barreiro-de Acosta M, Ginard D, Cabriada JL. Combination of granulocyte-monocyte apheresis and ustekinumab: Multicentre and retrospective study. GASTROENTEROLOGIA Y HEPATOLOGIA. 2024. DOI: 10.1016/j.gastrohep.2024.502195. IF: 2,2      Q3  D

De Vincentis A, Ampuero J, Terracciani F, D'Amato D, Gerussi A, Cristoferi L, Cazzagon N, Bonaiuto E, Floreani A, Calvaruso V, Cadamuro L, Degasperi E, Morgando A, Vanni E, Lleo A, Colapietro F, Alvaro D, Castellaneta A, Labanca S, Viganò M, Distefano M, Palitti VP, Ricci C, De Matthaeis N, Marzioni M, Gómez-Dominguez E, Montero JL, Molina E, Garcia-Buey L, Casado M, Berenguer M, Conde I, Simon MA, Fuentes J, Costa-Moreira P, Macedo G, Jorquera F, Morillas RM, Presa J, Sousa JM, Gomes D, Santos L, Olveira A, Hernandez-Guerra M, Aburruza L, Santos A, Carvalho A, Uriz J, Gutierrez ML, Perez E, Chessa L, Pellicelli A, Marignani M, Muratori L, Niro GA, Brunetto M, Ponziani FR, Pompili M, Marra F, Galli A, Mussetto A, Alagna G, Simone L, Bertino G, Rosina F, Cozzolongo R, Russello M, Baiocchi L, Saitta C, Terreni N, Zolfino T, Rigamonti C, Vigano R, Cuccorese G, Pozzoni P, Pedone C, Grasso S, Picardi A, Invernizzi P, Sacco R, Izzi A, Fernandez-Rodriguez C, Vespasiani-Gentilucci U, Carbone M. Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024. 2062-+. DOI: 10.1016/j.cgh.2024.05.008. IF: 11,6      Q1  D1

Mesonero F, Zabana Y, Fernández-Clotet A, Leo-Carnerero E, Caballol B, Núñez-Ortiz A, García MJ, Bertoletti F, Mínguez A, Suris G, Casis B, Ferreiro-Iglesias R, Calafat M, Jiménez I, Miranda-Bautista J, Lamuela LJ, Fajardo I, Torrealba L, Nájera R, Saíz-Chumillas RM, González I, Vicuña M, García-Morales N, Gutiérrez A, López-García A, Benítez JM, de Célix CR, Tejido C, Brunet E, Hernández-Camba A, Suárez C, Rodríguez-Lago I, Piqueras M, Castaño A, Ramos L, Sobrino A, Rodríguez-Grau MC, Elosua A, Montoro M, Baltar R, Huguet JM, Hermida B, Caballero-Mateos A, Sánchez-Guillén L, Bouhmidi A, Pajares R, Baston-Rey I, López-Sanromán A, Albillos A, Barreiro-de Acosta M. Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2024. DOI: 10.1177/17562848241234476. IF: 3,9      Q1  D2

Zare B, Gros B, Lal N, Dawson P, Sharma E, Dart RJ, Lim S, Ray S, Anderson SHC, Mawdsley J, Irving PM, Lees CW, Samaan MA. Effectiveness of risankizumab induction and maintenance therapy for refractory Crohn's disease: a real-world experience from a preapproval access programme and early access to medicines scheme. FRONTLINE GASTROENTEROLOGY. 2024. 499-506. DOI: 10.1136/flgastro-2024-102809. IF: 2,4      Q3  D

Ferrer CS, Gismero FM, Caballol B, Ballester MP, Rey IB, García AC, Bautista JM, Chumillas RS, Benitez JM, Sanchez-Delgado L, López-García A, de Celix CR, Abreu IA, Melcarne L, Santos RP, Marques-Camí M, Mateos AC, Díez CG, Calafat M, Galan HA, Vilaamil PV, Senosiain BC, Moya AG, Diaz CYR, Spicakova K, Marcos NM, Molina G, Parga LD, Angulo AR, del Campo LC, Grau MDR, Ramirez F, Pastrana BG, Partida IG, Mateu BB, Gonzalez EP, Iyo E, Gonzalez AE, Arnau ES, Villalba LH, Galindo PP, Medina LT, Alonso SM, Perez JAO, Sadornil CD, Ramirez LG, Martín-Arranz MD, Sanroman AL, Fernández A, Murgui VM, Suarez CC, Flórez-Diez P, Matilla MEL, Sicilia B, Escribano PS, Martin CM, Manosa M, Acosta MBD. Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort. GASTROENTEROLOGIA Y HEPATOLOGIA. 2024. DOI: 10.1016/j.gastrohep.2024.502197. IF: 2,2      Q3  D

Guerra I, Barros F, Chaparro M, Benítez JM, Martín-Arranz MD, de Francisco R, Piqueras M, de Castro L, Carbajo AY, Bermejo F, Mínguez M, Gutiérrez A, Mesonero F, Cañete F, González-Muñoza C, Calvo M, Sicilia B, Alfambra E, Rivero M, Lucendo AJ, Tardillo CA, Almela P, Bujanda L, van Domselaar M, Ramos L, Sánchez MF, Hinojosa E, Verdejo C, Gimenez A, Rodriguez-Lago I, Manceñido N, Calle JLP, Moreno MD, Delgado-Guillena PG, Antolin B, de la Piscina PR, Casanova MJ, Escribano PS, Arranz EM, Perez-Martínez I, Mena R, Morales NG, Granja A, Watts MMB, Francés R, Fernandez C, Calafat M, Roig-Ramos C, Vera MI, Carracedo A, Domènech E, Gisbert JP. Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry. DIGESTIVE DISEASES. 2024. 257-264. DOI: 10.1159/000537782. IF: 2      Q3  D

Puchades L, Herreras J, Iranzo MA, Reyes E, Crespo G, Rodriguez-Peralvarez M, Cortes L, Serrano T, Fernandez-Yunquera A, Montalva E, Berenguer M. Frailty Changes After Liver Transplantation. Results From a Spanish Multicenter Prospective Cohort Study. TRANSPLANTATION DIRECT. 2024. DOI: 10.1097/TXD.0000000000001599. IF: 1,9      Q3  D

Salazar J, Garcia-Planella E, Fernández-Clotet A, Esteve M, Gisbert JP, Busquets D, Lucendo A, Márquez L, Guardiola J, Martín-Arranz MD, Iglesias E, Monfort D, Villoria A, Cañete F, Bell O, Ricart E, Zabana Y, Chaparro M, Domènech E, Gordillo J. Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2024. 1301-1311. DOI: 10.1111/bcp.16017. IF: 3,1      Q2  D4

Din S, Segal J, Blackwell J, Gros B, Black CJ, Ford AC. Harms with placebo in trials of biological therapies and small molecules as induction therapy in inflammatory bowel disease: a systematic review and meta-analysis. LANCET GASTROENTEROLOGY & HEPATOLOGY. 2024. 1020-1029. DOI: 10.1016/S2468-1253(24)00264-4. IF: 30,9      Q1  D1

Gómez E, Montero JL, Molina E, García-Buey L, Casado M, Fuentes J, Simón MA, Díaz-González A, Jorquera F, Morillas RM, Presa J, Berenguer M, Conde MI, Olveira A, Macedo G, Garrido I, Hernández-Guerra M, Olivas I, Rodríguez-Taje S, Londoño M, Sousa JM, Ampuero J, Romero-González E, González-Padilla S, Escudero-García D, Carvalho A, Santos A, Gutiérrez ML, Pérez-Fernández E, Aburruza L, Uriz J, Gomes D, Santos L, Martínez-González J, Albillos A, Fernández-Rodríguez CM. Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024. 1604-1615. DOI: 10.1111/apt.18004. IF: 6,6      Q1  D1

Gros B, Ross H, Nwabueze M, Constantine-Cooke N, Derikx LAAP, Lyons M, O'Hare C, Noble C, Arnott ID, Jones GR, Lees CW, Plevris N. Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2024. DOI: 10.1177/17562848241258372. IF: 3,9      Q1  D3

Martin-Mateos R, Martínez-Arenas L, Carvalho-Gomes A, Aceituno L, Cadahía V, Salcedo M, Arias A, Lorente S, Odriozola A, Zamora J, Blanes M, Len O, Benítez L, Campos-Varela I, González-Diéguez ML, Lázaro DR, Fortún J, Cuadrado A, Carrasco NM, Rodríguez-Perálvarez M, Alvarez-Navascues C, Fábrega E, Serrano T, Cuervas-Mons V, Rodríguez M, Castells L, Berenguer M, Graus J, Albillos A. Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors. JOURNAL OF HEPATOLOGY. 2024. 904-912. DOI: 10.1016/j.jhep.2024.02.023. IF: 26,8      Q1  D1

Segura PS, Gomollón F, Casas D, Iborra M, Vela M, Fernández-Clotet A, Muñoz R, de la Filia IG, Prada MG, Rosique JAF, García MJ, de Francisco R, Arias L, Barrio J, Guerra I, Ponferrada A, Gisbert JP, Carrillo-Palau M, Calvet X, Márquez-Mosquera L, Gros B, Cañete F, Monfort D, Domínguez REM, Roncero O, Laredo V, Montoro M, Muñoz C, López-Cauce B, Lorente R, Coronel AF, Vega P, Martín D, Peña E, Varela P, Olivares S, Pajares R, Lucendo AJ, Sesé E, Mateu BB, Nos P, Domènech E, García-López S. Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study. DIGESTIVE AND LIVER DISEASE. 2024. 2060-2068. DOI: 10.1016/j.dld.2024.05.021. IF: 4      Q1  D3

Elford AT, Bishara M, Plevris N, Gros B, Constantine-Cooke N, Goodhand J, Kennedy NA, Ahmad T, Lees CW. Real-world effectiveness of upadacitinib in Crohn's disease: a UK multicentre retrospective cohort study. FRONTLINE GASTROENTEROLOGY. 2024. 297-304. DOI: 10.1136/flgastro-2024-102668. IF: 2,4      Q3  D

Gargallo-Puyuelo CJ, Ricart E, Iglesias E, de Francisco R, Gisbert JP, Taxonera C, Mañosa M, Peris MA, Navarrete-Muñoz EM, Sanahuja A, Guardiola J, Mesonero F, Tirado MR, Barrio J, Mendoza IV, Parga LD, García-Planella E, Calvet X, Arranz MDM, García S, Sicilia B, Carpio D, Domenech E, Gomollón F. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024. 2280-2290. DOI: 10.1016/j.cgh.2024.05.013. IF: 11,6      Q1  D1

Bastón-Rey I, Rodríguez-Lago I, Luque AM, Caballol B, Soutullo-Castiñeiras C, Bravo A, Castaño A, Gros B, Bernal L, Diz-Lois MT, Alonso-Galan H, Canete F, Castro B, Perez-Galindo P, Gonzalez-Munoza C, El Hajra I, Martínez-Montiel P, Alonso-Abreu I, Mesonero F, González-Vivo M, Peries L, Martín-Arranz E, Abril C, Marin-Jiménez I, Baltar R, Vicuña M, Moreno N, Brunet E, de Célix CR, Fajardo I, Cruz N, Calvino-Suárez C, Rojas-Feria M, Fernández-Clotet A, Gimeno-Torres M, Nieto-Garcia L, de la Iglesia D, Zabana Y, Suarez-Ferrer C, de Acosta MB. The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCU. INFLAMMATORY BOWEL DISEASES. 2024. 1-10. DOI: 10.1093/ibd/izae041. IF: 4,5      Q1  D2

Rodriguez-Tajes S, Garcia-Eliz M, Marcos AC, Varela IC, Ros AC, Loinaz C, Bravo MAG, Rodriguez-Peralvarez M, Fabrega E, Dieguez MLG, Vinaixa C, Pascasio JM, Vazquez IF, Baliellas C, Castells L, Salcedo M, Prieto M, Crespo G, Lens S, Forns X. The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis. LIVER INTERNATIONAL. 2024. 279-285. DOI: 10.1111/liv.15777. IF: 6      Q1  D2

Gómez-Labrador C, Ricart E, Iborra M, Iglesias E, Martín-Arranz MD, de Castro L, De Francisco R, García-Alonso FJ, Sanahuja A, Gargallo-Puyuelo CJ, Mesonero F, Casanova MJ, Mañosa M, Rivero M, Calvo M, Sierra-Ausin M, González-Muñoza C, Calvet X, García-López S, Guardiola J, García LA, Márquez-Mosquera L, Gutiérrez A, Zabana Y, Navarro-Llavat M, Poyatos RL, Piqueras M, Torrealba L, Bermejo F, Ponferrada-Díaz A, Pérez-Calle JL, Barreiro-de Acosta M, Tejido C, Cabriada JL, Marín-Jiménez I, Roncero O, Ber Y, Fernández-Salazar L, Aler BC, Lucendo AJ, Llaó J, Bujanda L, Villafranca CM, Domènech E, Chaparro M, Gisbert JP. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA. PHARMACEUTICS. 2024. DOI: 10.3390/pharmaceutics16050629. IF: 4,9      Q1  D2

Lagal DJ, Montes-Osuna AM, Ortiz-Olivencia A, Arribas-Parejas C, Ortiz-Alcántara A, Pescuezo-Castillo C, Bárcena JA, Padilla CA, Requejo-Aguilar R. Tumoral Malignancy Decreases Coupled with Higher ROS and Lipid Peroxidation in HCT116 Colon Cancer Cells upon Loss of PRDX6. ANTIOXIDANTS. 2024. DOI: 10.3390/antiox13070881. IF: 6      Q1  D2

Rodríguez-Lago I, Gros B, Sánchez K, Arumi D, Fortes MD, Cábez A, Gismero FM. Uso de herramientas digitales en salud en enfermedad inflamatoria intestinal. GASTROENTEROLOGIA Y HEPATOLOGIA. 2024. DOI: 10.1016/j.gastrohep.2024.502200. IF: 2,2      Q3  D

 

 

Publicaciones en 2023

Zamora-Olaya JM, Aparicio-Serrano A, Torres VA, González AP, Montero JL, Baena PB, Frias MS, Bru RC, Delgado JB, De la Mata M, Rodríguez-Perálvarez M. Changes in the Liver Transplant Waiting List after Expanding to the 'Up-to-Seven' Criteria for Hepatocellular Carcinoma. JOURNAL OF PERSONALIZED MEDICINE. 2023. DOI: 10.3390/jpm13121670.         IF: 3,4       Q2 D4

Rodriguez-Peralvarez ML, Gomez-Orellana AM, Majumdar A, Bailey M, McCaughan GW, Gow P, Guerrero M, Taylor R, Guijo-Rubio D, Hervas-Martinez C, Tsochatzis EA. Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort study. LANCET GASTROENTEROLOGY & HEPATOLOGY. 2023. 242-252. DOI: 10.1016/S2468-1253(22)00354-5.         IF: 35,7       Q1 D1

Medina-Medina R, Iglesias-Flores E, Benitez JM, Marin-Pedrosa S, Salgueiro-Rodriguez I, Linares CI, Gonzalez-Rubio S, Soto-Escribano P, Gros B, Rodriguez-Peralvarez ML, Cabriada JL, Chaparro M, Gisbert JP, Chicano-Galvez E, Ortea I, Ferrin G, Garcia-Sanchez V, Aguilar-Melero P. Development of a Prediction Model for Short-Term Remission of Patients with Crohn's Disease Treated with Anti-TNF Drugs. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023. DOI: 10.3390/ijms24108695.         IF: 5,6       Q1 D3

Espejo-Cruz ML, Gonzalez-Rubio S, Espejo JJ, Zamora-Olaya JM, Alejandre-Altamirano RM, Prieto-Torre M, Linares CI, Guerrero-Misas M, Barrera-Baena P, Poyato-Gonzalez A, Sanchez-Frias M, Ayllon MD, Rodriguez-Peralvarez ML, de la Mata M, Ferrin G. Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023. DOI: 10.3390/ijms24032558.         IF: 5,6       Q1 D3

Gros B, Perez AG, Pleguezuelo M, Ruiz FJS, de la Mata M, Rodriguez-Peralvarez M. Helicobacter Species and Hepato-Biliary Tract Malignancies: A Systematic Review and Meta-Analysis. CANCERS. 2023. DOI: 10.3390/cancers15030595.         IF: 5,2       Q2 D3

Gros B, Soto P, Causse M, Marin S, Iglesias E, Benitez JM. Impact of Clostridioides difficile infection in patients admitted with ulcerative colitis. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2023. 232-239. DOI: 10.1080/00365521.2022.2121175.         IF: 1,9       Q4 D

Lopez-Canovas JL, Herman-Sanchez N, del Rio-Moreno M, Fuentes-Fayos AC, Lara-Lopez A, Sanchez-Frias ME, Amado V, Ciria R, Briceno J, de la Mata M, Castano JP, Rodriguez-Peralvarez M, Luque RM, Gahete MD. PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing. EXPERIMENTAL AND MOLECULAR MEDICINE. 2023. 132-142. DOI: 10.1038/s12276-022-00917-7.         IF: 12,8       Q1 D1

de Célix CR, Martín-de-Carpi J, Pujol-Muncunill G, Palomino LM, Rodríguez-Belvís MV, Martín-Masot R, Navas-López VM, Ricart E, Casanova MJ, Rodríguez-Martínez A, Leo-Carnerero E, Alcaraz A, Mañosa M, Hernández V, Cobelas MCC, Sánchez C, Menchén L, Mesonero F, Barreiro-De Acosta M, Martinón-Torres N, Sandoval CT, Váazquez AR, Corsino P, Vicente R, Hernández-Camba A, Alonso JRA, Alonso-Abreu I, Millán AMC, Reverter LP, Castro B, Fernández-Salgado E, Cuiñas MMB, Benítez JM, Madero L, Clemente F, Riestra S, Jiménez-Treviño S, Boscá-Watts M, Crehuáa-Gaudiza E, Moya MC, Huguet JM, Largo-Blanco EM, Vives LG, Plaza R, Guerra I, Barrio J, Escartín L, Alfambra E, Cruz N, Muñoz MC, Pino MGM, Van Domselaar M, Botella B, Miquel DM, Grau MCR, De La Mano A, Ber Y, Iñiguez MC, Martínez-Pérez TD, Chaparro M, Gisbert JP. Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP. JOURNAL OF CLINICAL MEDICINE. 2023. DOI: 10.3390/jcm12144813.         IF: 3,9       Q2 D4

Requejo-Aguilar R. Cdk5 and aberrant cell cycle activation at the core of neurodegeneration. NEURAL REGENERATION RESEARCH. 2023. 1186-1190. DOI: 10.4103/1673-5374.360165.         IF: 6,1       Q1 D2

Montano-Loza AJ, Rodriguez-Peralvarez ML, Pageaux GP, Sanchez-Fueyo A, Feng S. Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation. JOURNAL OF HEPATOLOGY. 2023. 1199-1215. DOI: 10.1016/j.jhep.2023.01.030.         IF: 25,7       Q1 D1

Acosta MBD, Fernandez-Clotet A, Mesonero F, Garcia-Alonso FJ, Casanova MJ, Fernandez-de la Varga M, Canete F, de Castro L, Gutierrez A, Sicilia B, Cano V, Merino O, de Francisco R, Gonzalez-Partida I, Suris G, Torrealba L, Ferreiro-Iglesias R, Castro B, Marquez L, Sobrino A, Elorza A, Calvet X, Varela P, Vicente R, Bujanda L, Lario L, Mancenido N, Garcia-Sepulcre MF, Iglesias E, Rodriguez C, Piqueras M, Rosique JAF, Lucendo AJ, Benitez O, Garcia M, Olivares D, Gonzalez-Munoza C, Lopez-Cauce B, Alvarado VJM, Spicakova K, Brotons A, Bermejo F, Almela P, Ispizua N, Gilabert P, Tardillo C, Munoz F, Navarro P, Dominguez REM, Sendra P, Hinojosa E, Sainz E, Martin-Arranz MD, Carpio D, Ricart E, Caballol B, Nunez L, Barrio J, Gisbert JP, Iborra M, Calafat M, Hernandez V, Perez R, Cabriada JL, Domenech E, Rodriguez-Lago I. Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2023. 1036-1046. DOI: 10.14309/ajg.0000000000002152.         IF: 9,8       Q1 D2

Lagal DJ, Lopez-Grueso MJ, Pedrajas JR, Leto TL, Barcena JA, Requejo-Aguilar R, Padilla CA. Loss of PRDX6 Aborts Proliferative and Migratory Signaling in Hepatocarcinoma Cell Lines. ANTIOXIDANTS. 2023. DOI: 10.3390/antiox12061153.         IF: 7       Q1 D1

Chaparro M, Acosta D, Rodriguez C, Mesonero F, Vicuna M, Barreiro-de Acosta M, Fernandez-Clotet A, Martinez AH, Arroyo M, Vera I, Ruiz-Cerulla A, Sicilia B, Tapia MJC, Villafranca CM, Castro-Poceiro J, Cadilla JM, Sierra-Ausin M, Moron JMV, Lidon RV, Bermejo F, Royo V, Calafat M, Gonalez-Munoza C, Carnerero EL, Marcos NM, Torrealba L, Alonso-Galan H, Benitez JM, Nieto YB, Palomares MTDL, Garcia MJ, Munoz JF, Gonzalez EMA, Calvet X, Hernandez-Camba A, Dominguez REM, Menchen L, Calle JLP, Piqueras M, Sadornil CD, Botella B, Martinez-Perez TD, Ramos L, Rodriguez-Grau MC, San Miguel E, Forcelledo JLF, Salazar PMF, Garcia-Sepulcre M, Gutierrez A, Llao J, Abizanda ES, Bosca-Watts M, Iyo E, Keco-Huerga A, Bonil CM, Gonzalez EP, Perez-Galindo P, Varela P, Gisbert JP, To ReWard Study Grp. Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2023. 1237-1247. DOI: 10.14309/ajg.0000000000002145.         IF: 9,8       Q1 D2

Casanova MJ, NantFs O, VarTla P, Vela-Gonzalez M, Rivero M, Sierra-Gabarda O, Riestra S, Barreiro-de Acosta M, Martin-Rodriguez MD, Gargallo-Puyuelo CJ, Reygosa C, Munoz R, de la Filia-molina IG, Nunez-Ortiz A, Kolle L, Calafat M, Huguet JM, Iglesias-Flores E, Martinez-Perez TD, Bosch O, Duque-Alcorta JM, Frago-Larramona S, Van Domselaar M, Gonzalez-Cosano VM, Bujanda L, Rubio S, Mancebo A, Castro B, Garcia-Lopez S, de Francisco R, Nieto-Garcia L, Laredo V, Gutierrez-Casbas A, Mesonero F, Leo-Carnerero E, Canete F, Ruiz L, Gros B, del Moral-Martinez M, Rodriguez C, Chaparro M, Gisbert JP. Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2023. 60-70. DOI: 10.1111/apt.17525.         IF: 7,6       Q1 D1

Paz GB, Ochoa O, Peris MA, Barreiro-de Acosta M, Zabana Y, Vicens DG, Santos DC, Nunez FM, Miquel DMI, Catalan-Serra I, Sanchez VG, Alastruey CL, Villarin AL, Huguet JM, Ortiz CD, Mante XA, Canos AP, Morral ED, Nos P. The Risk of Developing Disabling Crohn's Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision Making. DIGESTIVE DISEASES. 2023. DOI: 10.1159/000531789.         IF: 2,3       Q4 D

Puchades L, Herreras J, Ibañez A, Reyes É, Crespo G, Rodríguez-Perálvarez M, Cortés L, Serrano T, Fernández-Yunquera A, Montalvá E, Berenguer M. Waiting time dictates impact of frailty: A Spanish multicenter prospective study. JHEP REPORTS. 2023. DOI: 10.1016/j.jhepr.2023.100840.         IF: 8,3       Q1 D2

 

Publicaciones en 2022

Montalva E, Rodriguez-Peralvarez M, Blasi A, Bonanad S, Gavin O, Hierro L, Llado L, Llop E, Pozo-Laderas JC, Colmenero J. TRANSPLANTATION. 2022. DOI: 10.1097/TP.0000000000004014

Rodriguez-Peralvarez M, Colmenero J, Gonzalez A, Gastaca M, Curell A, Caballero-Marcos A, Sanchez-Martinez A, Di Maira T, Herrero JI, Almohalla C, Lorente S, Cuadrado-Lavin A, Pascual S, Lopez-Garrido MA, Gonzalez-Grande R, Gomez-Orellana A, Alejandre R, Zamora-Olaya J, Bernal-Bellido C. AMERICAN JOURNAL OF TRANSPLANTATION. 2022. DOI: 10.1111/ajt.17021

Colmenero J, Tabrizian P, Bhangui P, Pinato DJ, Rodriguez-Peralvarez ML, Sapisochin G, Bhoori S, Pascual S, Senzolo M, Al-Adra D, Herrero JI, Petrowsky H, Dawson LA, Hosni A, Kutzke JL, Gastaca M, Watt KD. TRANSPLANTATION. 2022. DOI: 10.1097/TP.0000000000003998

Caballero-Marcos A, Citores MJ, Alonso-Fernandez R, Rodriguez-Peralvarez M, Valerio M, Morales JG, Cuervas-Mons V, Cachero A, Loinaz-Segurola C, Inarrairaegui M, Castells L, Pascual S, Vinaixa-Aunes C, Gonzalez-Grande R, Otero A, Tome S, Tejedor-Tejada J, Fernandez-Yunquera A, Gonzalez-Dieguez L, Nogueras-Lopez F, Blanco-Fernandez G, Diaz-Fontenla F, Bustamante FJ, Romero-Cristobal M, Martin-Mateos R, Arias-Milla A, Calatayud L, Marcacuzco-Quinto AA, Fernandez-Alonso V, Gomez-Gavara C, Munoz P, Banares R, Pons JA, Salcedo M. LIVER TRANSPLANTATION. 2022. DOI: 10.1002/lt.26389

Tellez L, Rodriguez ES, de Santiago ER, Llovet L, Gomez-Outomuro A, Diaz-Fontenla F, Lopez PA, Garcia-Eliz M, Amaral C, Sanchez-Torrijos Y, Fortea JI, Ferre-Aracil C, Rodriguez-Peralvarez M, Abadia M, Gomez-Camarero J, Olveira A, Calleja JL, Crespo J, Romero M, Hernandez-Guerra M, Berenguer M, Riveiro-Braciela M, Salcedo M, Rodriguez M, Londono MC, Albillos A. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2022. DOI: 10.1111/apt.16926

Gomez-Bravo MA, Prieto M, Navasa M, Sanchez-Antolin G, Llado L, Otero A, Serrano T, Jimenez-Romero C, Garcia-Gonzalez M, Valdivieso A, Gonzalez-Dieguez ML, de la Mata M, Pons JA, Salcedo M, Rodrigo JM, Cuervas-Mons V, Gonzalez A, Caralt M, Pardo F, Varo E, Crespo G, Rubin A, Guilera M, Aldea A, Santoyo J. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 2022. DOI: 10.17235/reed.2022.8549/2021

Guijarro LG, Cano-Martinez D, Toledo-Lobo MV, Ruiz-Llorente L, Chaparro M, Guerra I, Iborra M, Cabriada JL, Bujanda L, Taxonera C, Garcia-Sanchez V, Marin-Jimenez I, Barreiro-de Acosta M, Vera I, Martin-Arranz MD, Mesonero F, Sempere L, Gomollon F, Hinojosa J, Zoullas S, Monserrat J, Menor-Salvan C, Alvarez-Mon M, Gisbert JP, Ortega MA, Hernandez-Breijo B. BIOMEDICINES. 2022. DOI: 10.3390/biomedicines10030727

Casado-Llombart S, Velasco-de Andres M, Catala C, Leyton-Pereira A, Gutierrez-Cozar R, Suarez B, Armiger N, Carreras E, Esteller M, Ricart E, Ordas I, Gisbert JP, Chaparro M, Esteve M, Marquez L, Busquets D, Iglesias E, Garcia-Planella E, Martin-Arranz MD, Lohmann J, Ayata CK, Niess JH, Engel P, Panes J, Salas A, Domenech E, Lozano F. FRONTIERS IN IMMUNOLOGY. 2022. DOI: 10.3389/fimmu.2022.966184

Gutierrez A, Zapater P, Ricart E, Gonzalez-Vivo M, Gordillo J, Olivares D, Vera I, Manosa M, Gisbert JP, Aguas M, Sanchez-Rodriguez E, Bosca-Watts M, Laredo V, Camps B, Marin-Jimenez I, Zabana Y, Martin-Arranz MD, Munoz R, Navarro M, Sierra E, Madero L, Vela M, Perez-Calle JL, Sainz E, Calvet X, Arias L, Morales V, Bermejo F, Fernandez-Salazar L, Van Domselaar M, De Castro L, Rodriguez C, Munoz-Villafranca C, Lorente R, Rivero M, Iglesias E, Herreros B, Busquets D, Riera J, Martinez-Montiel MP, Roldon M, Roncero O, Hinojosa E, Sierra M, Barrio J, De Francisco R, Huguet J, Merino O, Carpio D, Ginard D, Munoz F, Marta P, Almela P, Argueelles-Arias F, Alcain G, Luis B, Mancenido N, Lucendo AJ, Varela P, Rodriguez-Lago I, Ramos L, Laura S, Sese E, Acosta MBD, Domenech E, Frances R. FRONTIERS IN MEDICINE. 2022. DOI: 10.3389/fmed.2022.823900

Chaparro M, Baston-Rey I, Fernandez-Salgado E, Garca JG, Ramos L, Palomares MTDL, Argelles-Arias F, Flores EI, Cabello M, Iturria SR, Ortiz AN, Charro M, Ginard D, Sadornil CD, Ochoa OM, Busquets D, Iyo E, Casbas AG, de la Piscina PR, Bosc-Watts MM, Arroyo M, Garca MJ, Hinojosa E, Gordillo J, Montiel PM, Jimnez BV, Ivorra CQ, Morn JMV, Huguet JM, Gonzlez-Lama Y, Santos AIM, Amo VM, Martn-Arranz MD, Bermejo F, Cadilla JM, de Clix CR, Salazar PF, San Romn AL, Jimnez N, Lpez SG, Figuerola A, Jimnez I, Cerezo FJM, Taxonera C, Varela P, de Francisco R, Monfort D, Arriero GM, Camba AH, Garca-Alonso FJ, Van Domselaar M, Villarroya RP, Nez A, Moranta FR, Marn-Jimnez I, Alonso VR, Rodrguez MDM, Camo-Monterde P, Tercero IG, Llavat MN, Garca LA, Cruz DH, Sulleiro S, Novella C, Vispo E, Barreiro-de Acosta M, Gisbert JP. INFLAMMATORY BOWEL DISEASES. 2022. DOI: 10.1093/ibd/izab357

Zabana Y, Marin-Jimenez I, Rodriguez-Lago I, Vera I, Martin-Arranz MD, Guerra I, Gisbert JP, Mesonero F, Benitez O, Taxonera C, Ponferrada-Diaz A, Piqueras M, Lucendo AJ, Caballol B, Manosa M, Martinez-Montiel P, Bosca-Watts M, Gordillo J, Bujanda L, Mancenido N, Martinez-Perez T, Lopez A, Rodriguez-Gutierrez C, Garcia-Lopez S, Vega P, Rivero M, Melcarne L, Calvo M, Iborra M, de-Acosta MB, Sicilia B, Barrio J, Perez JL, Busquets D, Perez-Martinez I, Navarro-Llavat M, Hernandez V, Argueelles-Arias F, Esteso FR, Meijide S, Ramos L, Gomollon F, Munoz F, Suris G, de Zarate JO, Huguet JM, Llao J, Garcia-Sepulcre MF, Sierra M, Dura M, Estrecha S, Coronel AF, Hinojosa E, Olivan L, Iglesias E, Gutierrez A, Varela P, Rull N, Gilabert P, Hernandez-Camba A, Brotons A, Ginard D, Sese E, Carpio D, Aceituno M, Cabriada JL, Gonzalez-Lama Y, Jimenez L, Chaparro M, Roman ALS, Alba C, Plaza-Santos R, Mena R, Tamarit-Sebastian S, Ricart E, Calafat M, Olivares S, Navarro P, Bertoletti F, Alonso-Galan H, Pajares R, Olcina P, Manzano P, Domenech E, Esteve M, Geteccu. JOURNAL OF CLINICAL MEDICINE. 2022. DOI: 10.3390/jcm11020421

Llovet LP, Gratacos-Gines J, Tellez L, Gomez-Outomuro A, Navascues CA, Riveiro-Barciela M, Vinuesa R, Gomez-Camarero J, Garcia-Retortillo M, Diaz-Fontenla F, Salcedo M, Garcia-Eliz M, Horta D, Guerrero M, Rodriguez-Peralvarez M, Fernandez-Rodriguez C, Albillos A, G-Abraldes J, Pares A, Londono MC. HEPATOLOGY COMMUNICATIONS. 2022. DOI: 10.1002/hep4.1889

Riestra S, Taxonera C, Zabana Y, Carpio D, Chaparro M, Barrio J, Rivero M, Lopez-Sanroman A, Esteve M, de Francisco R, Bastida G, Garcia-Lopez S, Manosa M, Martin-Arranz MD, Perez-Calle JL, Guardiola J, Munoz F, Arranz L, Cabriada JL, Garcia-Sepulcre MF, Navarro M, Montoro-Huguet MA, Ricart E, Bermejo F, Calvet X, Piqueras M, Garcia-Planella E, Marquez L, Minguez M, Van Domselar M, Bujanda L, Aldeguer X, Sicilia B, Iglesias E, Alcain G, Perez-Martinez I, Rolle V, Castano-Garcia A, Gisbert JP, Domenech E. JOURNAL OF CLINICAL MEDICINE. 2022. DOI: 10.3390/jcm11133915

Zabana Y, Marin-Jimenez I, Rodriguez-Lago I, Vera I, Martin-Arranz MD, Guerra I, Gisbert JP, Mesonero F, Benitez O, Taxonera C, Ponferrada-Diaz A, Piqueras M, Lucendo AJ, Caballol B, Manosa M, Martinez-Montiel P, Bosca-Watts M, Gordillo J, Bujanda L, Mancenido N, Martinez-Perez T, Lopez A, Rodriguez-Gutierrez C, Garcia-Lopez S, Vega P, Rivero M, Melcarne L, Calvo M, Iborra M, de Acosta MB, Sicilia B, Barrio J, Calle JLP, Busquets D, Perez-Martinez I, Navarro-Llavat M, Hernandez V, Arguelles-Arias F, Esteso FR, Meijide S, Ramos L, Gomollon F, Munoz F, Suris G, de Zarate JO, Huguet JM, Llao J, Garcia-Sepulcre MF, Sierra M, Dura M, Estrecha S, Coronel AF, Hinojosa E, Olivan L, Iglesias E, Gutierrez A, Varela P, Rull N, Gilabert P, Hernandez-Camba A, Brotons A, Ginard D, Sese E, Carpio D, Aceituno M, Cabriada JL, Gonzalez-Lama Y, Jimenez L, Chaparro M, Lopez-San Roman A, Alba C, Plaza-Santos R, Mena R, Tamarit-Sebastian S, Ricart E, Calafat M, Olivares S, Navarro P, Bertoletti F, Alonso-Galan H, Pajares R, Olcina P, Manzano P, Domenech E, Esteve M. JOURNAL OF CLINICAL MEDICINE. 2022. DOI: 10.3390/jcm11247540

Calafat M, Manosa M, Ricart E, Nos P, Iglesias-Flores E, Vera I, Lopez-SanRoman A, Guardiola J, Taxonera C, Minguez M, Martin-Arranz MD, de Castro L, de Francisco R, Rivero M, Garcia-Planella E, Calvet X, Garcia-Lopez S, Marquez L, Gomollon F, Barrio J, Esteve M, Munoz F, Gisbert JP, Gutierrez A, Hinojosa J, Arguelles-Arias F, Busquets D, Bujanda L, Perez-Calle JL, Sicilia B, Merino O, Martinez P, Bermejo F, Lorente R, Barreiro-de Acosta M, Rodriguez C, Garcia-Sepulcre MF, Monfort D, Canete F, Domenech E. JOURNAL OF CROHNS & COLITIS. 2022. DOI: 10.1093/ecco-jcc/jjab213

Lopez-Canovas JL, Herman-Sanchez N, Moreno-Montilla MT, Del Rio-Moreno M, Alors-Perez E, Sanchez-Frias ME, Amado V, Ciria R, Briceno J, de la Mata M, Castano JP, Rodriguez-Peralvarez M, Luque RM, Gahete MD. CLINICAL AND TRANSLATIONAL MEDICINE. 2022. DOI: 10.1002/ctm2.1102

Chaparro M, Baston-Rey I, Salgado EF, Garcia JG, Ramos L, Palomares MTDL, Arguelles-Arias F, Flores EI, Cabello M, Iturria SR, Ortiz AN, Charro M, Ginard D, Sadornil CD, Ochoa OM, Busquets D, Iyo E, Casbas AG, de la Piscina PR, Bosca-Watts MM, Arroyo M, Garcia MJ, Hinojosa E, Gordillo J, Montiel PM, Jimenez BV, Ivorra CQ, Moron JMV, Huguet JM, Gonzalez-Lama Y, Santos AIM, Amo VM, Arranz MDM, Bermejo F, Cadilla JM, de Celix CR, Salazar PF, San Roman AL, Jimenez N, Garcia-Lopez S, Figuerola A, Jimenez I, Cerezo FJM, Taxonera C, Varela P, de Francisco R, Monfort D, Arriero GM, Hernandez-Camba A, Alonso FJG, Van Domselaar M, Pajares-Villarroya R, Nunez A, Moranta FR, Marin-Jimenez I, Alonso VR, Rodriguez MDM, Camo-Monterde P, Tercero IG, Navarro-Llavat M, Garcia LA, Cruz DH, Kloss S, Passey A, Novella C, Vispo E, Barreiro-de Acosta M, Gisbert JP. JOURNAL OF CLINICAL MEDICINE. 2022. DOI: 10.3390/jcm11154518

Publicaciones en 2021

Espejo-Cruz ML, Gonzalez-Rubio S, Zamora-Olaya J, Amado-Torres V, Alejandre R, Sanchez-Frias M, Ciria R, De la Mata M, Rodriguez-Peralvarez M, Ferrin G. Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and CriticalAppraisal. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 202  22(23):-. DOI: 10.3390/ijms222313073.                   

IF: 5,924         Q1     D3

Amado V, Gonzalez-Rubio S, Zamora J, Alejandre R, Espejo-Cruz ML, Linares C, Sanchez-Frias M, Garcia-Jurado G, Montero JL, Ciria R, Rodriguez-Peralvarez M, Ferrin G, De la Mata M. Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation. CANCERS. 2021.  13(10):-. DOI: 10.3390/cancers13102476.                   

IF: 6,639         Q1     D3

Colmenero J, Rodriguez-Peralvarez M, Salcedo M, Arias-Milla A, Munoz-Serrano A, Graus J, Nuno J, Gastaca M, Bustamante-Schneider J, Cachero A, Llado L, Caballero A, Fernandez-Yunquera A, Loinaz C, Fernandez I, Fondevila C, Navasa M, Inarrairaegui M, Castells L, Pascual S, Ramirez P, Vinaixa C, Gonzalez-Dieguez ML, Gonzalez-Grande R, Hierro L, Nogueras F, Otero A, Alamo JM, Blanco-Fernandez G, Fabrega E, Garcia-Pajares F, Montero JL, Tome S, De la Rosa G, Pons JA. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. JOURNAL OF HEPATOLOGY. 2021.  74(1):148-155. DOI: 10.1016/j.jhep.2020.07.040.                    

IF: 25,083         Q1     D1

Rodriguez-Peralvarez M, Gomez-Bravo MA, Sanchez-Antolin G, De la Rosa G, Bilbao I, Colmenero J. Expanding Indications of Liver Transplantation in Spain: Consensus Statement and Recommendations by the Spanish Society of Liver Transplantation. TRANSPLANTATION. 2021.  105(3):602-607. DOI: 10.1097/TP.0000000000003281.                    IF: 4,939         Q1     D2

Pozo-Laderas JC, Guler I, Rodriguez-Peralvarez M, Robles JC, Mula A, Lopez-Cillero P, de la Fuente C. Early postoperative mortality in liver transplant recipients involving indications other than hepatocellular carcinoma. A retrospective cohortstudy. MEDICINA INTENSIVA. 202  45(7):395-410. DOI: 10.1016/j.medin.2020.02.004.                    IF: 2,491         Q3    

Lopez-Canovas JL, del Rio-Moreno M, Garcia-Fernandez H, Jimenez-Vacas JM, Moreno-Montilla MT, Sanchez-Frias ME, Amado V, Lopez FL, Fondevila MF, Ciria R, Gomez-Luque I, Briceno J, Nogueiras R, de la Mata M, Castano JP, Rodriguez-Peralvarez M, Luque RM, Gahete MD. Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma. CANCER LETTERS. 2021.  496():72-83. DOI: 10.1016/j.canlet.2020.10.010.                   

IF: 8,679         Q1     D2

Martina JA, Guerrero-Gomez D, Gomez-Orte E, Barcena JA, Cabello J, Miranda-Vizuete A, Puertollano R. A conserved cysteine-based redox mechanismsustains TFEB/HLH-30 activity under persistent stress. EMBO JOURNAL. 2021.  40(3):-. DOI: 10.15252/embj.202010579                   

IF: 11,598         Q1     D1

Giraldo E, Nebot VJ, Dordevic S, Requejo-Aguilar R, Alastrue-Agudo A, Zagorodko O, Arminan A, Martinez-Rojas B, Vicent MJ, Moreno-Manzano V. A rationally designed self-immolative linker enhances the synergism between a polymer-rock inhibitor conjugate and neural progenitor cells in the treatment of spinal cord injury. BIOMATERIALS. 2021.  276():-. DOI: 10.1016/j.biomaterials.2021.121052.                   

IF: 12,479         Q1     D1

Caballero-Marcos A, Salcedo M, Alonso-Fernandez R, Rodriguez-Peralvarez M, Olmedo M, Morales JG, Cuervas-Mons V, Cachero A, Loinaz-Segurola C, Inarrairaegui M, Castells L, Pascual S, Vinaixa-Aunes C, Gonzalez-Grande R, Otero A, Tome S, Tejedor-Tejada J, Alamo-Martinez JM, Gonzalez-Dieguez L, Nogueras-Lopez F, Blanco-Fernandez G, Munoz-Bartolo G, Bustamante FJ, Fabrega E, Romero-Cristobal M, Martin-Mateos R, Del Rio-Izquierdo J, Arias-Milla A, Calatayud L, Marcacuzco-Quinto AA, Fernandez-Alonso V, Gomez-Gavara C, Colmenero J, Munoz P, Pons JA. Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients. AMERICAN JOURNAL OF TRANSPLANTATION. 2021.  21(8):2876-2884. DOI: 10.1111/ajt.16599.                   

IF: 8,086         Q1     D1

Casanova MJ, Chaparro M, Nantes O, Benitez JM, Rojas-Feria M, Castro-Poceiro J, Huguet JM, Martin-Cardona A, Aicart-Ramos M, Tosca J, Martin-Rodriguez MD, Gonzalez-Munoza C, Manosa M, Leo-Carnerero E, Lamuela-Calvo LJ, Perez-Martinez I, Bujanda L, Hinojosa J, Pajares R, Arguelles-Arias F, Perez-Calle JL, Rodriguez-Gonzalez GE, Guardiola J, Barreiro-de Acosta M, Gisbert JP. Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2021.  53(12):1277-1288. DOI: 10.1111/apt.16361.                   

IF: 8,171         Q1     D1

Mesonero F, Castro-Poceiro J, Benitez JM, Camps B, Iborra M, Lopez-Garcia A, Torres P, Esteve M, Tosca J, Bertoletti F, Almela P, Calvet X, Vera I, Bujanda L, Gomollon F, Rodriguez C, Antolin B, Busquets D, Hernandez A, Rivero M, Miquel DMI, Castano-Garcia A, Gisbert JP, Domenech E, Lopez-Sanroman A. Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-alpha: results from the ENEIDA registry. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2021.  53(9):1021-1029. DOI: 10.1111/apt.16315.                   

IF: 8,171         Q1     D1

Algaba A, Guerra I, Ricart E, Iglesias E, Manosa M, Gisbert JP, Guardiola J, Minguez M, Castro B, de Francisco R, Nos P, Bertoletti F, Mesonero F, Barrio J, Martin-Arranz MD, Calvet X, Garcia-Lopez S, Sicilia B, Alcain G, Esteve M, Marquez L, Piqueras M, Jimenez L, Perez-Calle JL, Bujanda L, Garcia-Sepulcre M, Fernandez A, Moraleja I, Lorente RH, Garcia-Bosch O, Lamban A, Blazquez I, Rodriguez E, Huguet JM, Lucendo AJ, Almela P, Busquets D, de la Piscina PR, Perez M, Domenech E, Bermejo F. Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry. DIGESTIVE DISEASES AND SCIENCES. 2021.  66(6):2014-2023. DOI: 10.1007/s10620-020-06424-x.                   

IF: 3,199         Q3     D

Julia A, Martinez-Mateu SH, Domenech E, Canete JD, Ferrandiz C, Tornero J, Gisbert JP, Fernandez-Nebro A, Dauden E, Barreiro-de Acosta M, Perez C, Queiro R, Lopez-Longo FJ, Carazo JLS, Mendoza JL, Alperi M, Montilla C, Venegas JJP, Munoz F, Castaneda S, Aterido A, Lasanta ML, Marsal S, Fonseca E, Rodriguez J, Carreira P, Garcia V, Pinto-Tasende JA, Puig L, Ricart E, Blanco F, Gratacos J, Blanco R, Taboada VM, Fernandez E, Unamuno P, Gonzalez I, Garcia FG, Sanmarti R, Gutierrez A, Olive A, Estebaranz JLL, Garcia-Planella E, Torre-Alonso JC, Andreu JL, Ramirez DM, Fernandez B, Zamorano MAA, de la Cueva P, Mateu PN, Vela P, Vanaclocha F, Coromines H, Munoz S, Nolla JM, Herrera E, Gonzalez C, de la Fuente JLM, Vera M, Erra A, Roig D, Zea A, Comas ME, Tomas C, Zarco P, Pego JM, Saro C, Gonzalez A, Freire M, Garcia A, Diez E, Salvador G, Diaz C, Sanchez S, Dominguez AW, Mosquera JA, Ramirez J, Almaraz ER, Palau N, Tortosa R, Lopez M, Pluma A, Aterido A. Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study. EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2021.  75(9):1368-1382. DOI: 10.1038/s41430-021-00913-6.                   

IF: 4,016         Q2     D5

Chaparro M, Garre A, Ortiz AN, Palomares MTDL, Rodriguez C, Riestra S, Vela M, Benitez JM, Salgado EF, Rodriguez ES, Hernandez V, Ferreiro-Iglesias R, Diaz AP, Barrio J, Huguet JM, Sicilia B, Martin-Arranz MD, Calvet X, Ginard D, Alonso-Abreu I, Fernandez-Salazar L, Trastoy PV, Rivero M, Vera-Mendoza I, Vega P, Navarro P, Sierra M, Cabriada JL, Aguas M, Vicente R, Navarro-Llavat M, Echarri A, Gomollon F, del Rio EG, Pinero C, Casanova MJ, Spicakova K, de Zarate JO, Cortes ET, Gutierrez A, Alonso-Galan H, Hernandez-Martinez A, Marrero JM, Poyatos RL, Calafat M, Romero LM, Robledo P, Bosch O, Jimenez N, Comas ME, Duque JM, Coronel AMF, Sampedro MJ, Abizanda ES, Martinez BH, Pozzati L, Rosaenz HF, Suarez BC, Serrano PL, Lucendo AJ, Vicente MM, Bermejo F, Palanca JJR, Menacho M, Carmona A, Camargo R, Alsina ST, Maroto N, de la Puerta JN, Castro E, Marin-Jimenez I, Botella B, Sapina A, Cruz N, Forcelledo JLF, Bouhmidi A, Castano-Milla C, Opio V, Nicolas I, Kutz M, Bechiarelli AA, Gordillo J, Ber Y, Dominguez YT, Duran MTN, Mondejar SR, Martinez-Cerezo FJ, Kolle L, Sabat M, Ledezma C, Iyo E, Roncero O, Irisarri R, Lluis L, Gomez IB, Zapata EM, Alcala MJ, Pascual CM, Montealegre M, Mata L, Monrobel A, Camba AH, Hernandez L, Tejada M, Mir A, Galve ML, Soler M, Hervias D, Gomez-Valero JA, Barreiro-de Acosta M, Rodriguez-Artalejo F, Garcia-Esquinas E, Gisbert JP. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. JOURNAL OF CLINICAL MEDICINE. 2021.  10(13):-. DOI: 3390/jcm10132885.                   

IF: 4,241         Q1     D3

Ferre-Aracil C, Riveiro-Barciela M, Trapero-Marugan M, Rodriguez-Peralvarez M, Llovet LP, Tellez L, Sanchez-Torrijos Y, Diaz-Fontenla F, Salcedo-Plaza M, Alvarez-Lopez P, de la Mata M, Londono MC, Banares-Canizares R, Calleja JL. Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study. DIGESTIVE DISEASES AND SCIENCES. 2021.  66(8):2826-2832. DOI: 10.1007/s10620-020-06569-9.                   

IF: 3,199         Q3   

Publicaciones 2020

Ferrin G, Guerrero M, Amado V, Rodriguez-Peralvarez M, De la Mata M. Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2020. 21 (4):- DOI: 10.3390/ijms21041266 
IF: 4,556 Q: 1

Canete F, Manosa M, Perez-Martinez I, Barreiro-de Acosta M, Gonzalez-Sueyro RC, Nos P, Iglesias-Flores E, Gutierrez A, Bujanda L, Gordillo J, Leon RR, Casanova MJ, Villoria A, Rodriguez-Lago I, Serrano PL, Garcia-Herola A, Ramirez-de La Piscina P, Navarro-Llavat M, Taxonera C, Barrio J, Ramos L, Navarro P, Benitez-Leiva O, Calafat M, Domenech E. Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY. 2020. 11 (8) DOI: 10.14309/ctg.0000000000000218
IF: 3,968 Q: 2

Guasch M, Canete F, Ordas I, Iglesias-Flores E, Clos A, Gisbert JP, Taxonera C, Vera I, Minguez M, Guardiola J, Rivero M, Nos P, Gomollon F, Barrio J, de Francisco R, Lopez-Sanroman A, Martin-Arranz MD, Garcia-Planella E, Camargo R, Garcia-Lopez S, de Cas. Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2020. 35 (12):2080-2087 DOI: 10.1111/jgh.15084 
IF: 3,437 Q: 2

Gonzalez R, Rodriguez-Hernandez MA, Negrete M, Ranguelova K, Rossin A, Choya-Foces C, de la Cruz-Ojeda P, Miranda-Vizuete A, Martinez-Ruiz A, Rius-Perez S, Sastre J, Barcena JA, Hueber AO Padilla CA, Muntane J. Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer. REDOX BIOLOGY. 2020. 34 ():- DOI: 10.1016/j.redox.2020.101528 
IF: 9,986 Q: 1 D: 1

Rodriguez-Lago I, Del Hoyo J, Perez-Girbes A, Garrido-Marin A, Casanova MJ, Chaparro M, Fernandez-Clotet A, Castro-Poceiro J, Garcia MJ, Sanchez S, Ferreiro-Iglesias R, Baston I, Piqueras M, de Careda LEIB, Mena R, Suarez C, Cordon JP, Lopez-Garcia A, ; Marquez, L ; Arroyo, M; Alfambra, E ; Sierra, M; Cano, N; Delgado-Guillena, P; Morales-Alvarado, V; Aparicio, JC; Guerra, I; Aullo, C; Merino, O; Arranz, L; Hidalgo, MA; Llao, J; Plaza, R; Molina, G; Torres, P; Perez-Galindo, P; Romero, MG; Herrera-deGuise, C; Armesto, E; Mesonero, F; Frago-Larramona, S; Benitez, JM; Calvo, M; Martin, MDL; Elorza, A; Larena, A; Pena, E; Rodriguez-Grau, MD; de Miguel-Criado, J; Botella, B ; Olmos, JA; Lopez, L; Aguirre, U; Gisbert, JP. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2020. 8 (9):1056-1066 DOI: 10.1177/2050640620947579 
IF: 3,549 Q: 2

Casanova MJ, Chaparro M, Minguez M, Ricart E, Taxonera C, Garcia-Lopez S, Guardiola J, Lopez-San Roman A, Iglesias E, Beltran B, Sicilia B, Vera MI, Hinojosa J, Riestra S, Domenech E, Calvet X, Perez-Calle JL, Martin-Arranz MD, Aldeguer X, Rivero M, Monfo. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry. INFLAMMATORY BOWEL DISEASES. 2020. 26 (4):606-616 DOI: 10.1093/ibd/izz192 
IF: 4,261 Q: 2

Andujar X, Loras C, Gonzalez B, Socarras M, Sanchiz V, Bosca M, Domenech E, Calafat M, Rodriguez E, Sicilia B, Calvet X, Barrio J, Guardiola J, Iglesias E, Casanova MJ, Ber Y, Monfort D, Lopez-Sanroman A, Rodriguez-Lago I, Bujanda L, Marquez L, Martin-Arr. Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. 2020. 34 (3):1112-1122 DOI: 10.1007/s00464-019-06858-z 
IF: 3,149 Q: 1

Bonzon-Kulichenko E, Camafeita E, Lopez JA, Gomez-Serrano M, Jorge I, Calvo E, Nunez E, Trevisan-Herraz M, Bagwan N, Barcena JA, Peral B, Vazquez J. Improved integrative analysis of the thiol redox proteome using filter-aided sample preparation. JOURNAL OF PROTEOMICS. 2020. 214 ():- DOI: 10.1016/j.jprot.2019.103624 
IF: 3,509 Q: 2

Rodriguez-Peralvarez M, Salcedo M, Colmenero J, Pons JA. Increased incidence of COVID-19 among liver transplant patients in Europe. TRANSPLANT INTERNATIONAL. 2020. 33 (12):1823-1824 DOI: 10.1111/tri.13729 
IF: 3,177 Q: 1

Rodriguez-Hernandez MA, de la Cruz-Ojeda P, Lopez-Grueso MJ, Navarro-Villaran E, Requejo-Aguilar R, Castejon-Vega B, Negrete M, Gallego P, Vega-Ochoa A, Victor MV, Cordero MD, Del Campo JA, Barcena JA, Padilla CA, Muntane J. Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer. REDOX BIOLOGY. 2020. 36 ():- DOI: 10.1016/j.redox.2020.101510 
IF: 9,986 Q: 1 D: 1

Ciria R, Gomez-Luque I, Cortes M, Khorsandi SE, Ayllon MD, Rodriguez-Peralvarez M, Lopez-Cillero P, De La Mata M, O'Grady J, Heaton N, Briceno J. Interaction between tacrolimus, MELD score and acute kidney injury after liver transplantation. Analysis on a large contemporary bicenter meld-era series. CLINICAL TRANSPLANTATION. 2020. 34 (9):- DOI: 10.1111/ctr.13890 
IF: 1,665 Q: 3

Lopez-Grueso MJ, Lagal DJ, Garcia-Jimenez AF, Tarradas RM, Carmona-Hidalgo B, Peinado J, Requejo-Aguilar R, Barcena JA, Padilla CA. Knockout of PRDX6 induces mitochondrial dysfunction and cell cycle arrest at G2/M in HepG2 hepatocarcinoma cells. REDOX BIOLOGY. 2020. 37 ():- DOI: 10.1016/j.redox.2020.101737 
IF: 9,986 Q: 1 D: 1

Rodriguez-Peralvarez M, Salcedo M, Pons JA, Colmenero J. Letter: unknown denominator and misleading conclusions in COVID-19. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2020. 52 (7):1241-1242 DOI: 10.1111/apt.16038 
IF: 7,515 Q: 1 D: 1

Iborra M, Beltran B, Fernandez-Clotet A, Iglesias-Flores E, Navarro P, Rivero M, Gutierrez A, Sierra-Ausin M, Mesonero F, Ferreiro-Iglesias R, Hinojosa J, Calvet X, Sicilia B, Gonzalez-Munoza C, Antolin B, Gonzalez-Vivo M, Carbajo AY, Garcia-Lopez S, Mart. Real-world long-term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2020. 52 (6):1017-1030 DOI: 10.1111/apt.15958 
IF: 7,515 Q: 1 D: 1

Calafat M, Manosa M, Mesonero F, Guardiola J, Minguez M, Nos P, Vera I, Taxonera C, Iglesias E, Ricart E, Gisbert JP, Calvet X, Garcia-Lopez S, Monfort D, Calle JLP, Riestra S, Gomollon F, Garcia-Planella E, Bermejo F, Hernandez V, Martin-Arranz MD, Gutierrez A, Torres P, Canete F, Domenech E. Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry. JOURNAL OF CROHNS & COLITIS. 2020. 14 (9):1290-1298 DOI: 10.1093/ecco-jcc/jjaa055 
IF: 8,658 Q: 1

Rodriguez-Lago I, Castro-Poceiro J, Fernandez-Clotet A, Mesonero F, Lopez-Sanroman A, Lopez-Garcia A, Marquez L, Clos-Parals A, Canete F, Vicuna M, Nantes O, Merino O, Matallana V, Gordillo J, Elorza A, Vicente R, Casanova MJ, Ferreiro-Iglesias R,  Perez-Galindo, P (Perez-Galindo, Pablo)[ 16 ] ; Benitez, JM (Manuel Benitez, Jose)[ 17,18 ] ; Taxonera, C (Taxonera, Carlos)[ 19 ] ; Garcia, MJ (Jose Garcia, Maria)[ 20 ] ; Martin, E (Martin, Eduardo)[ 21 ] ; Aguirre, U (Aguirre, Urko)[ 22 ] ; Gisbert, JP (Gisbert, Javier P.)[ 13,14 ] . Tacrolimus induces short-term but not long-term clinical response in inflammatory bowel disease. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2020. 51 (9):870-879 DOI: 10.1111/apt.15687 
IF: 7,515 Q: 1 D: 1

Rodriguez-Peralvarez M, De la Mata M, Tsochatzis E. Tacrolimus Trough Concentrations After Liver Transplantation: Back to the Future. TRANSPLANTATION. 2020. 104 (4):E114-E114 DOI: 10.1097/TP.0000000000003086 
IF: 4,264 Q: 1 D: 1

Zabana Y, Panes J, Nos P, Gomollon F, Esteve M, Garcia-Sanchez V, Gisbert JP, Barreiro-de-Acosta M, Domenech E. The ENEIDA registry (Nationwide study on genetic and environmental determinants of inflammatory bowel disease) by GETECCU: Design, monitoring and functions. GASTROENTEROLOGIA Y HEPATOLOGIA. 2020. 43 (9):551-558 DOI: 10.1016/j.gastrohep.2020.05.007 
IF: 1,581 Q: 4

Chaparro M, Guerra I, Iborra M, Cabriada JL, Bujanda L, Taxonera C, Garcia-Sanchez V, Marin-Jimenez I, Barreiro-de Acosta M, Vera I, Martin-Arranz MD, Hernandez-Breijo B, Mesonero F, Sempere L, Gomollon F, Hinojosa J, Bermejo F, Beltran B, Pescador AR, Ba. Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 2020. 32 (5):588-596 DOI: 10.1097/MEG.0000000000001706 
IF: 2,251 Q: 4

Chaparro, M; Gordillo, J; Domenech, E; Esteve, M; Barreiro-de Acosta, M; Villoria, A; Iglesias-Flores, E; Blasi, M; Naves, JE; Benitez, O; Nieto, L; Calvet, X; Garcia-Sanchez, V; Villagrasa, JR; Marin, AC; Donday, MG; Abad-Santos, F; Gisbert, JP. Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2020. 115 (11):1802-1811 DOI: 10.14309/ajg.0000000000000926 
IF: 10,171 Q: 1 D: 1

Publicaciones 2019

Lopez-Grueso MJ, Gonzalez-Ojeda R, Requejo-Aguilar R, McDonagh B, Fuentes-Almagro CA, Muntane J, Barcena JA, Padilla CA. Thioredoxin and glutaredoxin regulate metabolism through different multiplex thiol switches. REDOX BIOLOGY. 2019. 21. DOI:10.1016/j.redox.2018.11.007.
IF: 7,793 Q: 1  D: 1

Bonzon-Kulichenko, Elena, Emilio Camafeita, Juan Antonio López, María Gómez-Serrano, Inmaculada Jorge, Enrique Calvo, Estefanía Núñez, et al. “Improved Integrative Analysis of the Thiol Redox Proteome Using Filter-Aided Sample Preparation.” Journal of Proteomics 2020 Mar 1;214:103624.  doi: 10.1016/j.jprot.2019.103624.
IF: 3,537 Q: 1

López-Grueso MJ, González R, Muntané J, Bárcena JA, Padilla CA. Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells. Antioxidants. 2019. 8 (10): 501. https://doi.org/10.3390/antiox8100501.
IF: 4,520 Q: 1

López-Grueso MJ, Tarradas Valero RM, Carmona-Hidalgo B, Lagal DJ, Perinado J, McDonagh B, Requejo-Aguilar R, Bárcena JA, Padilla CA. “Peroxiredoxin 6 Down-Regulation Induces Metabolic Remodeling and Cell Cycle Arrest in HepG2 Cells.” Antioxidants. 2019 Oct 23;8(11). pii: E505. doi: 10.3390/antiox8110505.
IF: 4,520 Q: 1

Padilla CA, Bárcena JA, López-Grueso MJ, Requejo-Aguilar R. The Regulation of TORC1 Pathway by the Yeast Chaperones Hsp31 Is Mediated by SFP1 and Affects Proteasomal Activity.” Biochimica et Biophysica Acta - General Subjects. 2019. 1863 (3). https://doi.org/10.1016/j.bbagen.2018.12.011.
IF: 3,681 Q: 2

Picazo C, McDonagh B, Peinado J, Bárcena JA, Matallana E, Aranda A. Saccharomyces Cerevisiae Cytosolic Thioredoxins Control Glycolysis, Lipid Metabolism, and Protein Biosynthesis under Wine-Making Conditions. Applied and Environmental Microbiology. 2019. 85 (7). https://doi.org/10.1128/AEM.02953-18.
IF: 4,077 Q: 1

Rodriguez-Peralvarez M, Amado V, de la Mata M. Letter: mechanistic target of rapamycin inhibitors as adjuvant therapy for patients with hepatocellular carcinoma undergoing liver transplantation. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2019. 50. 4. 478-479. DOI:10.1111/apt.15300.
IF: 7,731 Q: 1  D: 1

Garrido-Rodriguez M, Ortea I, Calzado MA, Munoz E, Garcia V. SWATH proteomic profiling of prostate cancer cells identifies NUSAP1 as a potential molecular target for Galiellalactone. JOURNAL OF PROTEOMICS. 2019. 193. 217-229. DOI:10.1016/j.jprot.2018.10.012.
IF: 3,537 Q: 1

Guerrero M, Ferrin G, Rodriguez-Peralvarez M, Gonzalez-Rubio S, Sanchez-Frias M, Amado V, Pozo JC, Poyato A, Ciria R, Ayllon MD, Barrera P, Montero JL, de la Mata M. mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2019. 20. 2. DOI:10.3390/ijms20020336.
IF: 4,183 Q: 2

Padilla CA, Barcena JA, Lopez-Grueso MJ, Requejo-Aguilar R. The regulation of TORC1 pathway by the yeast chaperones Hsp31 is mediated by SFP1 and affects proteasomal activity. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. 2019. 1863. 3. 534-546. DOI:10.1016/j.bbagen.2018.12.011.
IF: 3,681 Q: 2

Amado V, Rodriguez-Peralvarez M, Ferrin G, De la Mata M. Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria. JOURNAL OF HEPATOCELLULAR CARCINOMA. 2019. 6. 1-10. DOI:10.2147/JHC.S174549.

Publicaciones 2018

Rodriguez-Peralvarez M, Guerrero M, Barrera L, Ferrin G, Alamo JM, Ayllon MD, Artacho GS, Montero JL, Briceno J, Bernal C, Padillo J, Marin-Gomez LM, Pascasio JM, Poyato A, Gomez-Bravo MA, De la Mata M. Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation. TRANSPLANTATION. 2018; 102(12):2056-2064.
IF: 3,96 Q: 1  D: 1

Garcia-Borruel MM, Molina AJH, Peralvarez MLR, Rincon EM, Medrano IP, Ruiz FJS, Juanena LLC, Navarro MP, Rodriguez AN, Pastor CV.Post-colonoscopy colorectal cancer: Characteristics and predictive factors. MEDICINA CLINICA.2018.150(1)1-7.
IF:1,168 Q: 3

Alayon CG, Crespo CP, Pedrosa SM, Benítez  J, Flores E, Rodriguez I, Medina R, Garcia-Sanchez V. Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life. GASTROENTEROLOGIA Y HEPATOLOGIA. 2018; 41(1):22-29.
IF: 1,078 Q: 4

Chaparro M, Verreth A, Lobaton T, Gravito-Soares E, Julsgaard M, Savarino E, Magro F, Biron IA, Lopez-Serrano P, Casanova MJ, Gompertz M, Vitor S, Arroyo M, Pugliese D, Zabana Y, Vicente R, Aguas M, Shitrit ABG, Gutierrez A, Doherty GA, Fernandez-Salazar L, Cadilla JM, Huguet JM, O'Toole A, Stasi E, Marcos NM, Villoria A, Karmiris K, Rahier JF, Rodriguez C, Palomares MDL, Fiorino G, Benítez  JM, Principi M, Naftali T, Taxonera C, Mantzaris G, Sebkova L, Iade B, Lissner D, Bradley IF, Roman ALS, Marin-Jimenez I, Merino O, Sierra M, Van Domselaar M, Caprioli F, Guerra I, Peixe P, Piqueras M, Rodriguez-Lago I, Ber Y, van Hoeve K, Torres P, Gravito-Soares M, Rudbeck-Resdal D, Bartolo O, Peixoto A, Martin G, Armuzzi A, Garre A, Donday MG, de Carpi FJM, Gisbert JP. Long-Term Safety of In Utero Exposure to Anti-TNF alpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2018; 113(3):396-403.
IF: 10,231 Q: 1   D: 1

Ordas I, Domenech E, Manosa M, Garcia-Sanchez V, Iglesias-Flores E, Rodriguez-Moranta F, Marquez L, Merino O, Fernandez-Banares F, Gomollon F, Vera M, Gutierrez A, LLao J, Gisbert JP, Aguas M, Arias L, Rodriguez-Lago I, Munoz C, Alcaide N, Calvet X, Rodriguez C, Montoro MA, Garcia S, De Castro ML, Piqueras M, Pareja L, Ribes J, Panes J, Esteve M. Post-Operative Morbidity and Mortality of a Cohort of Steroid Refractory Acute Severe Ulcerative Colitis: Nationwide Multicenter Study of the GETECCU ENEIDA Registry. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2018; 113(7):1009-1016.
IF: 10,231 Q: 1   D: 1

Fernandez-Fernandez S, Bobo-Jimenez V, Requejo-Aguilar R, Gonzalez-Fernandez S, Resch M, Carabias-Carrasco M, Ros J, Almeida A, Bolanos JP. Hippocampal neurons require a large pool of glutathione to sustain dendrite integrity and cognitive function. REDOX BIOLOGY. 2018; 19:52-61.
IF: 7,126 Q: 1

Gonzalez R, Molina-Ruiz FJ, Barcena JA, Padilla CA, Muntane J. Regulation of Cell Survival, Apoptosis, and Epithelial-to-Mesenchymal Transition by Nitric Oxide-Dependent Post-Translational Modifications.ANTIOXIDANTS & REDOX SIGNALING. 2018; 29(13):1312-1332.
IF: 6,53 Q: 1   D: 1

Domenech E, Panes J, Hinojosa J, Annese V, Magro F, Sturniolo GC, Bossa F, Fernandez F, Gonzalez-Conde B, Garcia-Sanchez V, Dignass A, Herrera JM, Cabriada JL, Guardiola J, Vecchi M, Portela F, Ginard D. Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial. JOURNAL OF CROHNS & COLITIS. 2018; 12(6):687-694.
IF: 6,637 Q: 1

Taxonera C, Ponferrada A, Riestra S, Bermejo F, Saro C, Martin-Arranz MD, Cabriada JL, Barreiro-de Acosta M, de Castro ML, Lopez-Serrano P, Barrio J, Suarez C, Iglesias E, Arguelles-Arias F, Ferrer I, Marin-Jimenez I, Hernandez-Camba A, Bastida G, Van Domselaar M, Martinez-Montiel P, Olivares D, Rivero M, Fernandez-Salazar L, Nantes O, Merino O, Alba C, Gisberty JP, Martin-Rodriguez MD, Botella B, Carpio D, Ceballos D, Verdejo C, Morales I, Legido J, Penate M, Chaparro M, Algaba A, de Francisco R. Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease. JOURNAL OF CROHNS & COLITIS. 2018; 12(11):1270-1279.
IF: 6,637 Q: 1

Manzardo C, Londono MC, Castells L, Testillano M, Montero JL, Penafiel J, Subirana M, Moreno A, Aguilera V, Gonzalez-Dieguez ML, Calvo-Pulido J, Xiol X, Salcedo M, Cuervas-Mons V, Sousa JM, Suarez F, Serrano T, Herrero JI, Jimenez M, Fernandez JR, Gimenez C, del Campo S, Esteban-Mur JI, Crespo G, Moreno A, de la Rosa G, Rimola A, Miro JM. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study. AMERICAN JOURNAL OF TRANSPLANTATION. 2018; 18(10):2513-2522.
IF: 6,493 Q: 1   D: 1

Rivero-Juarez A, Aguado R, Lopez-Lopez P, Sanchez-Frias M, Frias M, Briceno J, de la Mata M, Torre-Cisneros J, Rivero A. Prevalence of hepatitis E virus infection in liver donors in Spain. CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24(11):1218-1219.
IF: 5,394 Q: 1   D: 1

Frontinan-Rubio J, Santiago-Mora RM, Nieva-Velasco CM, Ferrin G, Martinez-Gonzalez A, Gomez MV, Moreno M, Ariza J, Lozano E, Arjona-Gutierrez J, Gil-Agudo A, De la Mata M, Pesic M, Peinado JR, Villalba JM, Perez-Romasanta L, Perez-Garcia VM, Alcain FJ, Duran-Prado M. Regulation of the oxidative balance with coenzyme Q10 sensitizes human glioblastoma cells to radiation and temozolomide.RADIOTHERAPY AND ONCOLOGY.  2018; 128(2):236-244.
IF: 4,942 Q: 1

Paez-Vega A, Poyato A, Rodriguez-Benot A, Guirado L, Fortun J, Len O, Abdala E, Farinas MC, Cordero E, de Gracia C, Hernandez D, Gonzalez R, Torre-Cisneros J, Cantisan S. Analysis of spontaneous resolution of cytomegalovirus replication after transplantation in CMV-seropositive patients with pretransplant CD8+IFNG + response. ANTIVIRAL RESEARCH. 2018; 155:97-105.
IF: 4,307 Q: 1

Ayllon MD, Ciria R, Cruz-Ramirez M, Perez-Ortiz M, Gomez I, Valente R, O'Grady J, de la Mata M, Hervas-Martinez C, Heaton ND, Briceno J. Validation of artificial neural networks as a methodology for donor-recipient matching for liver transplantation. LIVER TRANSPLANTATION. 2018; 24(2):192-203.
IF: 3,752 Q: 1

Ampuero J, Jimeno C, Quiles R, Rosales JM, Llerena S, Palomo N, Cordero P, Serrano FJ, Urquijo JJ, Moreno-Planas JM, Ontanilla G, Hernández M, Ortega-Alonso A, Maraver M, Bonacci M, Rojas Á, Figueruela B, Forns X, Andrade RJ, Calleja JL, Diago M, Carmona I, de la Mata M, Buti M, Crespo J, Pascasio JM, Navarro JM, Salmerón J, Romero-Gómez M. Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C. JOURNAL OF HEPATOLOGY. 2018; 68(5):940-948. doi: 10.1016/j.jhep.2017.12.019.
IF: 15,040 Q: 1  D: 1

Chaparro M, Garre A, Ricart E, Iborra M, Mesonero F, Vera I, Riestra S, García-Sánchez V, Luisa De Castro M, Martin-Cardona A, Aldeguer X, Mínguez M, de-Acosta MB, Rivero M, Muñoz F, Andreu M, Bargalló A, González-Muñoza C, Pérez Calle JL, García-Sepulcre MF, Bermejo F, Huguet JM, Cabriada JL, Gutiérrez A, Mañosa M, Villoria A, Carbajo AY, Lorente R, García-López S, Piqueras M, Hinojosa E, Arajol C, Sicilia B, Conesa AM, Sainz E, Almela P, Llaó J, Roncero O, Camo P, Taxonera C, Domselaar MV, Pajares R, Legido J, Madrigal R, Lucendo AJ, Alcaín G, Doménech E, Gisbert JP; GETECCU study group Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry. Aliment Pharmacol Ther. 2018 Oct;48(8):839-851. doi: 10.1111/apt.14930.
IF: 7,357 Q: 1  D: 1

Medina-Caliz I, Garcia-Cortes M, Gonzalez-Jimenez A, Cabello MR, Robles-Diaz M, Sanabria-Cabrera J, Sanjuan-Jimenez R, Ortega-Alonso A, García-Muñoz B, Moreno I, Jimenez-Perez M, Fernandez MC, Ginés P, Prieto M, Conde I, Hallal H, Soriano G, Roman E, Castiella A, Blanco-Reina E, Montes MR, Quiros-Cano M, Martin-Reyes F, Lucena MI, Andrade RJ; Spanish DILI Registry. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry. Clinical Gastroenterology and Hepatology. 2018; 16(9):1495-1502. doi: 10.1016/j.cgh.2017.12.051.
IF: 7,683 Q: 1  D: 1

Garcia-Planella E, Manosa M, Chaparro M, Beltran B, Barreiro-de-Acosta M, Gordillo J, Ricart E, Bermejo F, Garcia-Sanchez V, Piqueras M, Llao J, Gisbert JP, Cabre E, Domenech E. Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2018; 53(2):152-157.
IF: 2,629 Q: 3

Ciria R, Navarro E, Sanchez-Frias M, Gallardo AB, Medina J, Ayllon MD, Gomez-Luque I, Ruiz-Rabelo J, Luque A, de la Mata M, Rufian S, Lopez-Cillero P, Briceno J. Preliminary results from the use of intraoperative real-time biliary oxygen monitoring in liver transplantation. CLINICAL TRANSPLANTATION. 2018; 32(12):Núm artículo e13433
IF: 1,518 Q: 3

Rodriguez-Lago I, Benítez  JM, Garcia-Sanchez V, Gutierrez A, Sempere L, Ginard D, Barreiro-de Acosta M, Cabriada JL. Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients' point of view. GASTROENTEROLOGIA Y HEPATOLOGIA. 2018; 41(7):423-431.
IF: 1,078 Q: 4

Aller R, Fernandez-Rodriguez C, lo Iacono O, Banares R, Abad J, Carrion JA, Garcia-Monzon C, Caballeria J, Berenguer M, Rodriguez-Peralvarez M, Miranda JL, Vilar-Gomez E, Crespo J, Garcia-Cortes M, Reig M, Navarro JM, Gallego R, Genesca J, Arias-Loste MT, Pareja MJ, Albillos A, Muntane J, Jorquera F, Sola E, Hernandez-Guerra M, Rojo MA, Salmeron J, Caballeria L, Diago M, Molina E, Bataller R, Romero-Gomez M. Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline. GASTROENTEROLOGIA Y HEPATOLOGIA. 2018; 41(5):328-349.
IF: 1,078 Q: 4

Rebollo-Roman A, Barrera-Martin A, Alcantara-Laguna MD, Iglesias-Flores E, Canada-Sanz E, Padillo-Cuenca JC, Molina-Puertas MJ, Calanas-Continente A. Non-oropharyngeal dysphagia with frequent Emergency Room attendance. NUTRICION HOSPITALARIA. 2018; 35(4):996-998.
IF: 0,845 Q: 4